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ABSTRACT
Mechanisms of Cr(VI)-Induced Carcinogenesis: the Involvement of Reactive Oxygen
Species and Signal Transduction Pathway
Suwei Wang

Although Cr(VI)-containing compounds have been widely recognized as
carcinogens for over 100 years, the mechanisms of their actions are not fully understood.
The overall objective of this study is to investigate the role of reactive oxygen species
(ROS) in Cr(VI)-induced carcinogenesis, focusing on tumor suppressor protein p53 and
regulatory signal transduction pathways. In the present study, the role of ROS in p53
activation was investigated and the following conclusions were obtained: (a) Cr(VI) is able
to activate p53 protein; (b) ROS, especially COH radical, are responsible for the p53
activation induced by Cr(VI). In addition, we presented a mechanism of cellular ROS
generation induced by Cr(VI). After entering the cell, Cr(VI) can be reduced to Cr(V).
During the reduction process, molecular oxygen is reduced to O2 - radical, which generates
H2O2 via dismutation. Cr(V) reacts with H2O2 to generate COH radicals via a Fenton-like
reaction. For the molecular mechanism of p53 activation induced by Cr(VI), posttranslational modifications, including Ser 15 phosphorylation, Lys 382 acetylation, and
mdm2 dissociation were found to play a crucial role. Erk, but not p38 kinase, is responsible
for the phosphorylation of Ser 15 induced by Cr(VI). The present study also investigated
the interaction of NF-κB and p53 protein in Cr(VI)-induced apoptosis. NF-κB activation is
capable of diminishing Cr(VI)-induced p53 activation, and protecting cells from apoptosis.
These studies on Ras overexpressed cells presented a new scheme for ROS generation from
Cr(VI)-induced cells different from the one described above. O2 - radical, which is produced
by overexpressed Ras protein, reacts with Cr(VI) to generate Cr(V). The Cr(V) further
reacts with H2O2, which is produced by O2 - radical dismutation, to produce COH radical.
These results implicate Cr(VI) and O2 - radical into the signal transduction pathways
mediated by Ras protein. Since Ras signaling pathway is important in regulating cell
proliferation, the involvements of Cr(VI) in Ras signal transduction pathway may be one of
the mechanisms for Cr(VI)-induced carcinogenesis. This study provides a molecular basis
for the understanding of the mechanisms of Cr(VI)-induced cellular responses, and
contributes to a better understanding for the carcinogenic process induced by this metal.
These new findings also have the impact on other carcinogens and chemical particles that
have a ROS generation machinery similar to Cr(VI).
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OVERVIEW
Cr(VI)-containing compounds are well established carcinogens (1). They are used
widely in industry and are found in the environment (2). Human exposure to these
compounds occurs primarily in occupational settings and through environmental
contamination such as from toxic waste sites. Both industrial and environmental exposures
to Cr(VI) have been associated with an increased incidence of cancers in the respiratory
system (1-5). Although Cr(VI)-containing compounds have been recognized as irritants and
carcinogens for over 100 years, the mechanisms of their actions are not fully understood.
Studies have shown that the carcinogenic effects of Cr(VI) are attributed to cellular uptake
because Cr(VI) but not Cr(III) actively enters cells by the anion transport system (6, 7).
After entering the cell, Cr(VI) is reduced by cellular reductants to its lower oxidation states,
Cr(V) and Cr(IV) (8). These reactive chromium intermediates are capable of generating a
whole spectrum of reactive oxygen species (ROS), including superoxide radical (O2 -),
hydrogen peroxide (H2O2), and hydroxyl radical (COH) (9-12). Since these reactive
metabolites of Cr(VI), especially ROS, mediate most of the cellular effects of Cr(VI), such
as DNA strand breaks, base modification, lipid peroxidation, and nuclear transcription
factor NF-kB activation (9-14), they are considered to play major roles in the carcinogenic
process of Cr(VI). The overall objective of this study is to investigate the role of ROS in
Cr(VI)-induced carcinogenesis, focusing on tumor suppressor protein p53 and regulatory
signal transduction pathways.
Role of ROS in Cr(VI)-induced p53 activation (Section I)
Apoptosis, or programmed cell death, is a genetically controlled response for cells
to commit suicide. Apoptotic cell death is considered to be an ongoing, normal event in the
control of cell population. However, apoptosis can also be induced by a variety of stimuli,
resulting in the loss of cell population. Recent evidence has suggested that the abnormal
apoptosis may be involved in the pathogenesis of a variety of human cancers (15),
indicating the involvement of apoptosis in carcinogenesis.
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One of the important regulatory machineries for apoptosis is tumor suppressor
protein p53. The p53 tumor suppressor protein plays an important role in protecting cells
from tumorgenetic alteration by inducing cell growth arrest or apoptosis (16-20).
Mutational inactivation of p53 has been found to be involved in various human cancers,
indicating the importance of p53 in human carcinogenesis (17). P53 protein can be
activated in response to various stimuli including DNA damage agents (21-24). Previous
studies from our laboratory have shown that Cr(VI) is able to cause DNA damage through
ROS mediated reactions (12). In this study, we presented a pathway for the ROS generation
in Cr(VI)-stimulated cells. After entering the cells through anion transport system, Cr(VI)
can be reduced Cr(V) by cellular reductase. During the reduction process, molecular
oxygen is reduced to O2 - radical, which generates H2O2 via dismutation. Cr(V) reacts with
H2O2 to generate COH radicals via a Fenton-like reaction (Cr(V) + H2O2 → Cr(VI) + COH
+ OH-). Furthermore, the role of the ROS in p53 activation was investigated and the
following conclusions were obtained: (a) Cr(VI) is able to activate p53 protein in a timeand dose-dependent manner; (b) ROS play a key role in the p53 activation induced by
Cr(VI); (c) Among the Cr(VI)-generated ROS, COH radical is responsible for p53
activation.
This study presents a mechanism for the cellular ROS generation induced by
Cr(VI), provides direct evidence for the involvement of ROS in p53 activation, and points
out that COH radical is the key species which is responsible for the p53 activation. It may be
noted that many other metal ions, mineral particles, and chemical carcinogens, such as
cobalt, nickel, vanadium, asbestos, and silica are reported to be capable of generating COH
radical (25-29). It is possible that those agents may have the same function as Cr(VI); i.e.,
they may cause p53 activation through COH radical as a common messenger. Since p53 is
involved in various biological processes, such as regulation of genes involved in the cell
cycle, cell growth arrest after DNA damage, and apoptosis, COH radical could be an
important messenger in signal transduction pathways involved in carcinogenesis.
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The molecular mechanisms of Cr(VI)-induced p53 activaiton (Section II)
Previous section suggests that Cr(VI) activates p53 protein via COH radical
mediated reactions (30). Furthermore, we extended our investigation regarding the possible
mechanisms of the activation of p53 induced by Cr(VI).
Murine double minute-2 (mdm2) proto-oncoprotein and post-translational
modifications of p53 protein, including multiple phosphorylation and acetylation, are
considered to be two major factors to regulate p53 activation (31-33). Mdm2 binds to p53,
negatively regulating p53 activity (34-38). By contrast, the post-translational modifications
function to stabilize and activate p53 (39-43). In response to stimuli, different sites of p53
protein become phosphorylated and acetylated by distinct kinases, depending on both
stimulator and cellular environment. Phosphorylation and acetylation on the different sites
synergistically contribute to the activation of p53 protein (44).
The results obtained from this study support the following conclusions: (a) In the
process of p53 activation induced by Cr(VI), post-translational modifications, including Ser
15 phosphorylation, Lys 382 acetylation, and mdm2 disassociation, play crucial roles; (b)
Erk, but not p38 kinase, is responsible for the phosphorylation of the Ser 15 induced by
Cr(VI).
This study provides a new insights into the mechanisms of Cr(VI)-induced p53
activation.
Interaction of NF-κ
κB and p53 in Cr(VI)-induced apoptosis (Section III)
The nuclear transcription factor NF-κB plays a crucial role in cell survival and
proliferation as well as immune responses by regulating the expression of a variety of genes
(45-48). Unlike p53, NF-κB functions as a pro- or anti-apoptotic mediator depending on
different stimuli and cellular systems (49). A number of stimuli are reported to activate both
NF-κB and p53, suggesting the possible interaction of these two signal transduction
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pathways. Recently, accumulating evidence demonstrates the existence of crosstalk
between NF-κB and p53. However, the relationship between these two transcription factors
is not fully understood. In this section, we used Cr(VI) as a stimulator for p53 activation to
investigate the role of NF-κB in Cr(VI)-induced apoptosis and the possible involvement of
p53.
The results from the present studies indicate that NF-κB activation is capable of
diminishing Cr(VI)-induced p53 activation, and protecting cells from apoptosis. It appears
that activation of NF-κB may play a key role in carcinogenic process induced not only by
Cr(VI), but also by other chemical and particle carcinogens as well.
Role of ROS and Cr(VI) in Ras mediated signal transduction (Section IV)
ROS have been traditionally considered to be involved in the pathogenesis of
various diseases and carcinogenesis (13,50-53). In addition, recent studies suggest that ROS
act as intracellular second messengers in regulating normal cell functions. ROS have been
reported to activate a variety of transcription factors and signal proteins, including NF-6B,
AP-1, c-fos, tumor suppressor protein p53, and protein kinase C (PKC) (30, 54-57).
However, an excessive production of ROS may contribute to the carcinogenic process by
inducing DNA damage and abnormal activation of certain cell growth regulators (50, 58,
59).
The Ras p21 protein has important regulatory roles in the control of signal
transduction, cell proliferation, and differentiation (60-63). The mutationally activated Ras
genes have been found in a variety of human cancers and experimental animals (64, 65).
Recently, it has been reported that overexpression of Ras protein generates O2 - radical (66).
This radical is involved in Ras signal transduction to the nucleus, mediating Ras-induced
cell cycle progression. These studies implicated O2 - radical into the Ras signaling pathway,
which plays a key role in cell growth modulation. However, the mechanisms of how O2 radical carries the Ras signal to the nucleus is still unclear.

4

The results obtained in this study support our hypothesis that O2 - radical, which is
produced by overexpressed Ras protein, reacts with Cr(VI) to generate Cr(V). The Cr(V)
further reacts with H2O2, which is produced by O2 - radical dismutation, to produce COH
radical. It is the COH radical that is responsible for transmitting signals from Ras protein to
the nucleus.
The results obtained from this section present a new scheme for ROS generation
from Cr(VI)-induced cells. It also implicates Cr(VI) into the signal transduction pathways
mediated by Ras protein. Since Ras signaling pathway is important in regulating cell
proliferation, the involvement of Cr(VI) in Ras signal transduction pathway may be one of
the mechanisms for Cr(VI)-induced carcinogenesis.

In summary, this study investigated the role of ROS in Cr(VI)-induced apoptosis,
the molecular mechanisms of Cr(VI)-induced p53 activation, the interaction between NFκB and p53 in Cr(VI)-induced apoptosis, and the role of ROS in Ras mediated signal
transduction. The results provide a molecular basis for the understanding of the
mechanisms of Cr(VI)-induced cellular responses and contribute to a better understanding
for the carcinogenic process induced by Cr(VI). These new findings also have the impact
on other carcinogens and chemical particles that have a ROS generation machinery similar
to Cr(VI).
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SECTION I
The role of hydroxyl radical as a messenger in p53 activation
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I.1.

ABSTRACT
The present study investigates whether reactive oxygen species (ROS) are involved

in p53 activation and if they are, which species is responsible for the activation. Our
hypothesis is that hydroxyl radical (COH) functions as a messenger for the activation of this
tumor suppressor protein. Human lung epithelial cells (A549) were used to test this
hypothesis. Cr(VI) was employed as the source of ROS due to its ability to generate a
whole spectrum of ROS inside the cell. Cr(VI) is able to activate p53 by increasing the
protein levels and enhancing both the DNA binding activity and transactivation ability of
the protein. Increased cellular level of superoxide radicals (O2 -), hydrogen peroxide (H2O2)
and COH radicals were detected upon the addition of Cr(VI) to the cells. Superoxide
dismutase (SOD), by enhancing the production of H2O2 from O2 - radicals, increased p53
activity. Catalase, a hydrogen peroxide scavenger, eliminated COH radical generation and
inhibited p53 activation. Sodium formate and aspirin, COH radical scavengers, also
suppressed p53 activation. Deferoxamine, a metal chelator, inhibited p53 activation by
chelating Cr(V) to make it incapable of generating radicals from H2O2. NADPH, which
accelerated the one-electron reduction of Cr(VI) to Cr(V) and increased COH radical
generation, enhanced p53 activation. Thus, COH radical generated from Cr(VI) reduction in
A549 cells is responsible for Cr(VI) induced p53 activation.
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I.2.

INTRODUCTION
The p53 tumor suppressor protein plays an important role in protecting cells from

tumorgenetic alteration (19,22). Mutational inactivation of p53 has been found to be
involved in various human cancers, indicating the importance of p53 in human
carcinogenesis (42). It has been reported that more than 50% of human cancers contain
mutations in p53 gene (15,22). P53 is activated in response to a variety of stimuli, such as
UV, gamma radiation, hypoxia, nucleotide deprivation, etc (7,10,18,23). The activation of
p53 may cause either cell division cycle arrest or apoptosis (1,9,19,40).
P53 can be considered as one of the oxidative stress response transcription factors
(42). There are several cysteine residues in the central domain of the p53 protein. These
residues are crucial for the p53 protein binding to the specific DNA sequence. Redox
modulation at a posttranslational level often occurs by reduction or oxidation of the
disulfide bond. A reduced state is required for these cysteine residues to ensure that p53
protein would bind to specific consensus DNA and transactivate target genes (12,27,29).
Among these genes, more than half of them are reported to be involved in the metabolism
of reactive oxygen species (ROS) (28). While ROS are also believed to be involved in the
activation of p53 protein induced by ultraviolet and ion irradiation (11,44). Questions
remain to be answered concerning which species among ROS plays a key role in the
process of p53 activation.
Cr(VI)-containing compounds are considered to be well established carcinogens (5).
They are potential inducers of tumors in experimental animals and active agents in the
induction of DNA damage, such as DNA strand breakage (5,13,20,21,41,43,46). Industrial
exposure to these compounds is reported to be associated with a higher incidence of human
lung cancer (13,21). Environmental exposure to Cr(VI) could induce lung toxicity in the
short-term and carcinogenecity over a long-term (6). Cr(VI) and Cr(III) are the two stable
chromium oxidation states found in nature. Unlike Cr(III), Cr(VI) can enter the cell through
the anion transport system (3,4). After entering the cell, Cr(VI) is reduced by cellular
reductants to its lower oxidation states, Cr(V) and Cr(IV) (39). These reactive chromium
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intermediates are capable of generating a whole spectrum of ROS (31-33,35). ROS
generated by these reactions can cause DNA strand breaks, base modification, lipid
peroxidation, and nuclear transcription factor NF-kB activation (31-33,35,37,48). In present
studies, Cr(VI) was used as the source of ROS to investigate the role of ROS in p53
activation and the following questions will be answered: (a) whether Cr(VI) is able to
activate p53 protein; (b) if so, whether ROS play a role in this process and which species is
responsible for p53 activation.
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I.3.

MATERIALS AND METHODS

Materials
Sodium dichromate (Na2Cr2O7) and chromium fluoride (Cr(III)) were purchased
from Aldrich ( Milwaukee, WI). Deferoxamine, 5,5-dimethyl-1-pyrroline N-oxide
(DMPO), superoxide dismutase (SOD), catalase, sodium formate, aspirin, b-nicotinamide
adenine dinucleoride phosphate (NADPH), and 2’,7’-dichlorofluorescin diacetate (DCFHDA) were purchased from Sigma ( St. Louis, MO). Dihydroethidium was purchased from
Molecular Probes (Eugene, OR). The spin trap, DMPO, was purified by charcoal
decolorization and vacuum distillation and was free of ESR detectable impurities.
Cell culture
A human lung epithelial cell line (A549 cells) was obtained from American Type
Culture Colletion (ATCC) (Rockville, MD). The cells were maintained in F-12K nutrient
mixture (Kaighn’s Modification) medium (F-12K) (Gibco BRL, Grand Island, NY)
supplemented with 10% fetal bovine serum (FBS), 2 mM glutamine and 1,000 units/ml
penicillin-streptomycin.
Nuclear extraction
Nuclear extracts were prepared by a modified method of Ye, et al (47).
A549 cells suspended in F-12K plus 10% FBS were cultured in 35 mm cell culture plates at
5 × 106 cells/plate for 24 hours. The cells were treated with chromium and other agents for
3 hours. After washing the cells with 5 ml PBS twice, fresh F-12K medium with 10% FBS
was added. Then the cells were incubated at 37°C for various times. At the end of the
culture period, cells were harvested and treated with 500 l lysis buffer (50 mM KCl, 0.5%
NP-40, 25 mM HEPES pH 7.8, 1 mM phenylmethylsulfonyl fluoride (PMSF), 10 g/ml
leupeptin, 20 g/ml aprotinin, and 100 M DTT) on ice for 4 minutes. After centrifugation
at 14,000 rpm for 1 minute, the supernatant was saved as a cytoplasmic extract. The nuclei
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were washed once with the same buffer without NP-40. The washed nuclei were suspended
in a 100 l volume of extraction buffer (500 mM KCl, 10% glycerol with the same
concentrations of HEPES, PMSF, leupeptin, aprotinin and DTT as the lysis buffer), and
pipetted three times for proper mixing. After centrifugation at 14,000 rpm for 5 minutes, the
supernatant was harvested and this nuclear protein extract was stored at -70°C. The
concentration was determined using a BCA protein assay reagent (Pierce, Rockford, IL).
Western blot
The nuclear extraction proteins were used for western blot analysis to determine the
p53 protein level. This analysis was carried out as described before (8). Briefly, samples
(20 g protein) denatured with SDS were electrophoretically separated on 10% TrisGlycine gels (Novex, San Diego, CA) and were transferred to nitrocellulose membrane
(Schleicher & Schuell, Keene, NH). The membrane was pre-blocked in milk buffer (Trisbuffered saline Tween (TBS-T) containing 5% non-fat milk) for 20 minutes and exposed
for 1 hour to 0.8 g/ml affinity-purified mouse antibody to p53 protein in fresh milk buffer.
The membrane was rinsed and incubated with a 1: 2000 dilution of HRP conjugated goat
anti-mouse IgG for 1 hour. The membrane was then washed with TBS-T and antibody
binding sites were visualized by ECL western blotting detection reagents (Amersham
Pharmacia Biotech, Piscataway, NJ). All the antibodies were from Santa Cruz
Biotechnology (Santa Cruz, CA).
Oligonucleotide
Oligonucleotides were synthesized by GIBCO BRL Life Technologies (Grand
Island, NY). A p53 binding sequence (5’-AGACATGCCTAGACATTGT-3’) was used to
synthesize a p53 binding oligonucleotide. The synthesized single-stranded oligonucleotides
were deprotected at 50°C overnight, dried in a speed vacuum and then dissolved in the TrisEDTA buffer. Complimentary strands were denatured at 80°C for 5 minutes and annealed
at room temperature. The double-stranded probe was labeled with 32P-ATP (Amersham,
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Arlington Heights, IL) using a T4 kinase (Bethesda Research Laboratories, Gaithersburg,
MD).
Electrophoretic mobility shift assay (EMSA)
The DNA-protein binding reaction was conducted in a 24 l reaction mixture
including 1 g poly dI.dC (Sigma, St. Louis, MO), 3 g nuclear protein extract, 3 g BSA,
4 × 104 cpm of 32P-labeled oligonucleotide probe (1 g), 0.1 g p53 antibody Ab-1
(Oncogene, Cambridge, MA), 3 l distilled water and 12 l of 2 × reaction buffer (24%
glycerol, 24 mM HEPES pH 7.9, 8 mM Tris-HCL pH 7.9, 2 mM EDTA, 2 mM DTT). This
mixture was incubated on ice for 10 minutes in the absence of the radiolabelled probe, then
incubated for 20 minutes at room temperature in the presence of radiolabelled probe. After
the incubation, the DNA-protein complexes were resolved on a 3.5% acrylamide gel that
had been pre-run at 210 V for 30 minutes with 0.5 × Tris-boric acid-EDTA (TBE) buffer.
The loaded gel was run at 210 V for 60 minutes, then dried and placed on Kodak X-OMAT
film (Eastman Kodak, Rochester, NY) for autoradiography. The film was developed after
overnight exposure at -70°C.
The concentrations given in the figure legends are final concentrations. All
experiments were performed at room temperature and under ambient air except those
specifically indicated.
Assay for p53 transcriptional activation
Human lung epithelial A549 cells (3 × 105) suspended in 1 ml of 10% FBS F-12K
medium were seeded into each well of a 6-well plate. After being incubated at 37°C for 24
hours, the cells were transiently transfected by 1 g p53-luciferase reporter plasmid and 1
g -gal plasmid in reduced-serum medium. The cells were incubated overnight and then
washed. Fresh 10% FBS F-12K medium was added. Twenty four hours later, the cells were
exposed to various concentrations of Cr(VI) for 3 hours. After being washed, the
transfected cells were incubated overnight in fresh F-12K medium. Then the cells were
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extracted with 400 l reporter lysis buffer in 4°C for 2 hours. The luciferase activity was
measured with 80 l cell lysate, using a Monolight luminometer, Model 3010 (Analytical
Luminescence Laboratory, Sparks, MD). -gal activity was determined by using a method
described before (47). The results are expressed as relative p53 activity compared to
controls after normalizing by -gal activity.
ESR measurements
ESR spin trapping was used to examine free radical generation. The use of this
method is necessary because of the reactive nature of the free radicals to be studied. This
technique involves an addition-type reaction of a short-lived radical with a diamagnetic
compound (spin trap) to form a relatively long-lived free radical product, the so-called spin
adduct, which can be studied by conventional ESR. The intensity of the spin adduct signal
corresponds to the amount of short-lived radicals trapped, and the hyperfine splittings of the
spin adduct are generally characteristic of the original, short-lived, trapped radical.
All measurements were conducted with a Varian E9 ESR spectrometer and a flat
cell assembly. Hyperfine couplings were measured (to 0.1G) directly from magnetic field
separation using potassium tetraperoxochromate (K3CrO8) and 1,1-diphenyl-2picrylhydrazyl (DPPH) as reference standards. The EPRDAP 2.0 program (U.S. EPR Inc.,
Clarksville, MD) was employed for data acquisition and analysis. Reactants were mixed in
test tubes to a total final volume of 0.5 ml. The reaction mixture was then transferred to a
flat cell for ESR measurement.
Cellular O2 - and H2O2 assay
Dihydroethidium (DE) is a superoxide radical (O2 -) specific dye (2,26). DE was
dissolved in DMSO at 2 mM and kept at -20°C. The cells were plated onto a glass slip in
the 24 well plate at 1 × 104/well 16 hours before treatment. DE was added to the cell culture
together with the various treatments and the cells were incubated at 37°C for 30 minutes.
The final DMSO concentration in the cell culture was 0.1%. After being stained, the cells
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were washed with PBS and fixed with 10% buffered formalin. The slip was mounted on a
glass slide and observed using a Saratro 2000 (Molecular Dynamics, Inc., Sunnyrale, CA)
laser scanning confocal microscope (Optiphot-2, Nikon, Inc., Melville, PA) fitted with an
argon-ion laser. 2’,7’-Dichlorofluorescin diacetate (DCFH-DA) at 2 M was used to
monitor the hydrogen peroxide (H2O2) level inside the cells according to the methods
reported earlier (14,17,49).
Oxygen consumption measurements
Oxygen consumption measurements were carried out with a Gilson oxygraph
equipped with a Clark electrode (Gilson Medical Electronics, Middleton, WI). These
measurements were made from mixtures containing 1.0 × 106/ml cells and various
treatments in a total volume of 1.5 ml. The oxygraph was calibrated with media equilibrated
with oxygen of known concentrations.
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I.4.

RESULTS

P53 activation by Cr(VI) is dose and time-dependent
Human lung epithelial A549 cells were used to study induction of p53 activation by
Cr(VI). The cells were incubated with different concentrations of Cr(VI) for 3 hours. After
washing the cells, fresh F-12K medium supplemented with 10% FBS was added. The cells
were then incubated at 37°C overnight. P53 protein level and DNA binding activity were
analyzed in the nuclear extracts. As shown in Fig. 1a, the p53 protein level increased
following exposure to increasing concentrations of Cr(VI). The DNA binding activity of the
same protein was also investigated by electrophoretic mobility shift assay (EMSA). The
results are shown in Fig. 1b. From this figure, a similar concentration dependent pattern
was found, i.e., the higher the concentration of Cr(VI), the higher the binding activity of
p53 protein.
Fig. 2 shows the effect of time on the p53 protein level and its DNA binding
activity. A549 cells were treated with 150 M Cr(VI) for 3 hours. Fresh F-12K medium
with 10% FBS was added. The cells were then collected at different times. The same
nuclear extractions were used for measuring protein level (Fig. 2a) and DNA binding
activity (Fig. 2b). The results indicate that both p53 protein level and DNA binding activity
were enhanced in a time dependent fashion from 0-16 hours post-exposure.
Fig. 3 shows the results of the luciferase assay for p53 activity. Increasing the
Cr(VI) concentration up to 100 M enhanced p53 activation, while further increase in
Cr(VI) concentration resulted in a lower p53 activation, possibly due to Cr(VI)-induced
apoptosis.
Detection of free radicals
ESR spin trapping was used to detect free radical generation from Cr(VI)-stimulated
A549 cells. Fig. 4a shows the spectrum recorded from a mixture containing Cr(VI), A549
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cells, and DMPO (a spin trapping reagent). This spectrum consists of a 1:2:2:1 quartet with
splittings of aH = aN = 14.9 G, where aH and aN denote hyperfine splittings of the hydrogen and the nitroxyl nitrogen, respectively. Based on these splittings constants, the
1:2:2:1 quartet was assigned to DMPO/COH adduct. The arrow head at the right side shows
a small peak, which was assigned to a Cr(V)-NADPH complex as reported earlier (38).
Addition of SOD, a O2 - scavenger whose function is to convert O2 - to H2O2, dramatically
increased the DMPO/COH adduct signal (Fig. 4b). Catalase, a H2O2 scavenger, and sodium
formate, a scavenger of COH radical, decreased the generation of COH radical (Fig. 4c and
4d). A metal chelator, deferoxamine, suppressed the DMPO/COH signal (Fig. 4e). NADPH,
a cofactor of certain flavoenzymes, such as GSSG-R (glutathione reductase), which
catalyzes the conversion of Cr(VI) to Cr(V), enhanced the generation of both Cr(V) and
COH radical (Fig. 4f). H2O2 dramatically increased

the DMPO/COH signal with reduction of

the Cr(V) peak (Fig. 4g).
Specific fluorescent dyes were used to directly visualize free radical generation
inside the A549 cells. Dihydroethidium (DE), a specific fluorescent dye for O2 -, and
DCFH-DA, a fluorescent dye for H2O2, were used to detect the generation of O2 - and H2O2,
respectively. Both O2 - and H2O2 can be visualized in untreated cells (Fig. 5). Upon
stimulation with Cr(VI), O2 - radicals were dramatically enhanced (Fig. 5a). The H2O2 level
also increased, although not as significantly as O2 - radicals (Fig. 5b). Addition of catalase
decreased the amount of H2O2 inside the cell (Fig. 5b, Cr(VI) + Cat), while addition of SOD
increased its level (Fig. 5b, Cr(VI) + SOD). The changes occurred within 30 minutes. The
fluorescent dyes exhibited a red or orange color after being oxidized by ROS.
Oxygen consumption
As shown before, COH radicals were produced via Cr(V) mediated Fenton-like
reaction ( H2O2 + Cr(V) → Cr(VI) + •OH + OH-). The H2O2 was generated by the
dismutation of O2 - radicals. These radicals were generated by one-electron reduction of
molecular oxygen during the reduction of Cr(VI) by flavoenzymes in the presence of
NADPH. A Gilson oxygraph equipped with a Clark electrode was used to measure oxygen
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consumption in Cr(VI)-stimulated A549 cells. As shown in Fig. 6, addition of Cr(VI)
enhanced the oxygen consumption and NADPH slightly accelerated it. Cr(III) did not have
any significant effect.
COH

radical is responsible for Cr(VI)-induced p53 activation
A549 cells were incubated with Cr(VI) in the presence of various reagents for 3

hours (Fig. 7). After washing the cells, the fresh F-12K medium with 10% FBS was added.
The cells were then incubated overnight and were harvested for extraction of nuclear
proteins. The protein level was analyzed by western blot. The results are shown in Fig. 7.
As shown in this figure, p53 protein level in the untreated A549 cells (lane 1) was below
the detection limits. Cells treated with Cr(VI) showed an elevated p53 protein level (lane 2).
Cr(III), due to its inability to enter the cell, had no effect (lane 3). SOD increased the
protein level through the generation of H2O2 and COH radical (lane 4), while catalase,
sodium formate, and aspirin scavenged COH radical and diminished the protein level (lane
5-7). Deferoxamine chelated Cr(V) and decreased p53 protein induction (lane 8). NADPH
on the other hand enhanced the generation of COH radical and increased p53 protein
induction in A549 cells (lane 9). These results suggest that COH radical is responsible for
Cr(VI)-induced p53 protein activation.
Results shown above support the generation of ROS in this cellular system. The
reaction scheme presented in Fig. 8 may best accommodate the pathways for COH radical
generation in Cr(VI)-stimulated A549 cells and the resultant p53 activation.
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I.5.

DISCUSSION
The present study shows that Cr(VI) is able to induce the activation of p53 protein

in the epithelial cell line, A549. COH radicals play a key role in this Cr(VI)-induced p53
activation.
Using ESR with a loop-gap resonator, previous studies have demonstrated that
reduction of Cr(VI) in live animals generates Cr(V) (24). Flavoenzymes, such as
glutathione reductase (GSSG-R), are likely reductants for Cr(V) generation. Using a noncellular chemical system, our earlier studies have shown that reduction of Cr(VI) by GSSGR in the presence of NADPH generates Cr(V) (39). The results obtained from the present
studies show that Cr(VI) can be reduced by the whole cells to Cr(V). During the reduction
process, molecular oxygen is reduced to O2 - radical, which generates H2O2 via dismutation.
Cr(V) reacts with H2O2 to generate COH radicals via a Fenton-like reaction (Cr(V) + H2O2
→ Cr(VI) + COH + OH-) (Fig. 8).
The COH radical is the key species among ROS responsible for p53 activation. The
following experimental observations support the above conclusion. (a) Sodium formate, an
COH radical scavenger, inhibited p53 activation. (b) Deferoxamine, which chelated Cr(V) to
make it incapable of generating COH radical from H2O2, diminished p53 activation. (c)
SOD enhanced the p53 activation instead of attenuating it. This is due to the fact that SOD
increased the H2O2 generation by catalyzing O2 - dismutation, as demonstrated by
fluorescent staining, and increased the COH radical generation through a Fenton-like
reaction, as demonstrated by ESR spin trapping. (d) A mixture of Cr(VI) and A549 cells
increased molecular oxygen consumption. (e) Catalase, which depleted H2O2 and blocked
COH radical generation, inhibited the p53 activation.
H2O2 is an endogenous oxidant that is commonly used to investigate the role of
ROS in p53 activation. However, inconsistent observations were reported from different
laboratories (16, 27). For example, it has been observed that H2O2 can activate p53 protein
and its target gene Bax (16). It has also been reported that H2O2 decreased p53
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transactivation by weakening its binding to the specific DNA sequence (27). The results
obtained from the present study show that while H2O2 itself is unable to cause p53
activation, it can indirectly activate p53 through its ability to generate COH radical upon
reaction with metal ions. The following experimental observations support this conclusion.
(a) Sodium formate, an COH radical scavenger, inhibited p53 activation. This COH radical
scavenger does not react with H2O2. Similar results were obtained using a different COH
radical scavenger, aspirin. (b) Deferoxamine, which inhibited p53 activation due to
chelation of Cr(V) to make this metal ion unable to generate COH radical from H2O2, did
not react with H2O2. While H2O2 is not a direct p53 stimulating agent, it functions as a
precursor for COH radical generation. Thus, elimination of H2O2 inhibited p53 activation.
This may explain the reported controversy concerning the role of H2O2 in p53 activation.
As for O2 - radical, it is not a direct p53 stimulating agent either. As shown in the
present studies, a specific O2 - radical scavenger, SOD, enhanced p53 activation instead of
causing inhibition. The enhancement of p53 activation is due to the generation of H2O2
from O2 - radical catalyzed by SOD. O2 - radical is generated via reduction of molecular
oxygen as demonstrated by the oxygen consumption assay. Thus, the following scheme can
best accommodate p53 activation induced by ROS reaction:
O2

O2 -

SOD

H2O2

Cr(V)

COH

p53 activation

Cr(VI) is a well-established carcinogen. Although the mechanism of its action is
still unclear, free radical reactions mediated by this metal ion are believed to play a key
role. For example, COH radicals generated by reactive chromium intermediates, such as
Cr(V) and Cr(IV), can cause NF-kB activation, DNA strand breakage, and cell injury.
These radicals also function as messengers to induce p53 activation in response to Cr(VI)induced cellular injury. The process of p53-dependent cell cycle arrest or apoptosis
functions to repair or remove the damaged cells. Because of the fundamental importance of
cell cycle arrest and apoptosis, which are regulated by p53, alternations of these pathways
can enhance cancer development. Thus, an understanding of p53 activation, especially the
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role of ROS, is essential for understanding the overall carcinogenic process induced not
only by Cr(VI), but also by other chemical carcinogens as well.
It may be noted that many other metal ions, mineral particles, and chemical
carcinogens, such as cobalt, nickel, vanadium, asbestos, and silica are reported to be
capable of generating COH radical (25,30,34,36,45). It is possible that those agents may
have the same function as Cr(VI); i.e., they may cause p53 activation through COH radical
as a common messenger. Since p53 is involved in various biological processes, such as
regulation of genes involved in the cell cycle, cell growth arrest after DNA damage, and
apoptosis, COH radical could be an important messenger in signal transduction pathways
involved in carcinogenesis processes.
In conclusion, (a) Cr(VI) is able to induce the p53 activation; (b) ROS is involved in
its mechanism of activation; (c) COH radical functions as a messenger in the p53 activation
processes.
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FIGURES
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Fig. 1. Dose-dependent p53 activation induced by Cr(VI). The A549 cells were adjusted
to a density 1 × 106/ml and treated for 3 hours with different concentrations of
Cr(VI). The cells were washed, added to fresh medium, and incubated overnight.
The nuclear extraction proteins were used for western blot and DNA binding
activity assay. (a) Western blot for p53 protein level. Lane 1, untreated cells; lane 2,
cells + 50 M Cr(VI); lane 3, cells + 100 M Cr(VI); lane 4, cells + 150 M
Cr(VI); lane 5, cells + 200 M Cr(VI); lane 6, cells + 300 M Cr(VI). (b) DNA
binding assay for p53 protein. Lane1, untreated cells; lane 2, cells + 50 M Cr(VI);
lane 3, cells + 100 M Cr(VI); lane 4, cells + 150 M Cr(VI); lane 5, cells + 200
M Cr(VI).
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Fig. 2 Time-dependent p53 activation induced by Cr(VI). The A549 cells were adjusted
to a density 1 × 106/ml and treated for 3 hours with 150 M Cr(VI). The cells were
washed, added to fresh medium, and collected at different times. The nuclear
extraction proteins were used for western blot and DNA binding activity assay. (a)
Western blot for p53 protein level. Lane 1, 0 hour; lane 2, 3 hours; lane 3, 4 hours
after the 3 hours of treatment; lane 4, 8 hours after the 3 hours of treatment; lane 5,
overnight after the 3 hours of treatment. (b) DNA binding assay for p53 protein. The
experimental conditions are the same as (a).
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Fig. 3 Luciferase assay for Cr(VI)-induced p53 activation. Human lung epithelial A549
cells (3 × 105) suspended in 1 ml of 10% FBS F-12K medium were seeded into a 6well plate. After being incubated at 37°C in a humidified atmosphere of 5% CO2 for
24 hours, the cells were transit transfected by p53-luciferase reporter plasmid and gal plasmid in reduced-serum medium. The cells were incubated overnight, then
washed, added to fresh 10% FBS F-12K medium, and incubated for 24 hours. The
cells were exposed to various concentrations of Cr(VI) for 3 hours, washed, added
to fresh F-12K medium, and incubated overnight. The p53 activity was measured by
luciferase activity assay as described in the Materials and Methods. Results are
presented as relative p53 induction compared to the untreated control cells (means
and standard deviation of three repeated assays). Asterisks indicate a significant
increase from control (p < 0.05).
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Fig. 4 Generation of free radicals from Cr(VI)-stimulated A549 cells. (a) ESR
spectrum recorded 10 minutes after the addition of 1 mM Cr(VI) to 1 × 106 cells/ml
and 100 mM DMPO in a phosphate buffered solution (pH 7.4). (b) Same as (a) but
with 1,000 units/ml SOD added. (c) Same as (a) but with 10,000 units/ml catalase
added. (d) Same as (a) but with 50 mM sodium formate added. (e) Same as (a) but
with 2 mM deferoxamine added. (f) Same as (a) but with 2 mM NADPH added. (g)
Same as (a) but with 2 mM H2O2 added.
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a

b

Fig. 5 Generation of O2 - radicals and H2O2 inside the A549 cells. (a) Fluorescent
stainning for O2 - radicals. The cells were incubated in the absence (left panel) or
presence (right panel) of 150 M Cr(VI) in the presence of 2 M dihydroethidium
for 30 minutes. (b) Fluorescent stainning of H2O2. The cells were incubated with 5
M DCFH-DA in the absence (control) or presence of 150 M Cr(VI); Cr(VI) +
10,000 units/ml catalase; and Cr(VI) + 1,000 units/ml SOD for 30 minutes. The
cells were washed once in PBS and fixed with 10% formalin. The images were
captured with a confocal microscope.
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Fig. 6 Oxygen consumption by Cr(VI)-stimulated A549 cells. A incubation mixture
contained 1 mM Cr(VI), 1 × 106 cells/ml cells and various reagents (NADPH, 1mM;
Cr(III), 1 mM) as indicated. Values are means and standard deviation of three
repeated experiments. Asterisks indicate a significant increase from the control (p <
0.05).
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Fig. 7 Effects of ROS on Cr(VI)-induced p53 activation. The A549 cells were adjusted
to a density 1 × 106/ml and treated for 3 hours with different stimuli. The cells were
washed, added to fresh medium, and incubated overnight. The nuclear extraction
proteins were used for western blot. Lane 1, untreated cells; lane 2, cells + 150 M
Cr(VI); lane 3, cells + 150 M Cr(III); lane 4, cells + 150 M Cr(VI) + 1,000
units/ml SOD; lane 5, cells + 150 M Cr(VI) + 10,000 units/ml catalase; lane 6,
cells + 150 M Cr(VI) + 50 mM sodium formate; lane 7, cells + 150 M Cr(VI) + 2
mM aspirin; lane 8, cells + 150 M Cr(VI) + 2 mM deferoxamine; lane 9, cells +
150 M Cr(VI) + 2 mM NADPH.
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Fig. 8 Schematic representation of possible mechanism of COH radical generation in
Cr(VI)-stimulated A549 cells.
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SECTION II
Mechanisms of Cr(VI)-induced p53 activation: the role of
phosphorylation, mdm2 and ERK
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II.1.

ABSTRACT
The present study investigated the molecular mechanisms of p53 activation induced

by Cr(VI), using human lung epithelial A549 cells. Cr(VI) increased both protein level and
transactivation ability of p53 protein. The activation of p53 is at the protein level instead of
the transcriptional level. The degradation of p53 was dramatically decreased upon the
stimulation by Cr(VI). In addition, Cr(VI) treatment decreased the interaction of p53 with
mdm2 proto-oncoprotein, which blocks the transactivation ability of p53 and promotes the
degradation of p53 protein. In response to Cr(VI) treatment, p53 protein became
phosphorylated and acetylated on Ser 15 and Lys 382, respectively. The phosphorylation
levels on either Ser 20 or Ser 392 did not show any significant alterations. Since previous
studies report that it is Ser 20 but not Ser 15 phosphorylation that contributes to mdm2
dissociation from p53, the results obtained from the current investigation suggest a different
mechanism: Ser 15 instead of Ser 20 may play a key role in the dissociation of mdm2 in
response to Cr(VI). Erk, a member of mitogen-activated protein kinase, acts as the upstream
kinase for the phosphorylation of the p53 Ser 15 site.
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II.2.

INTRODUCTION
The p53 tumor suppressor protein plays an important role in protecting cells from

fatal genetic injury (1, 2). Mutational inactivation of p53 protein has been found to be
involved in various cancers in humans and experimental animals (2). A variety of mutations
in the p53 gene have been reported in more than 50% of human cancers, suggesting a
crucial role for p53 protein in maintaining normal cell growth (2, 3).
Normally, p53 has a very short half-life and the protein levels are low (4). A
lengthening of the half-life and rapid accumulation of p53 protein were observed in
response to a variety of stimuli, such as UV light, gamma radiation, hypoxia, and nucleotide
deprivation (5-8). A key player in this modulation is the murine double minute-2 (mdm2)
proto-oncoprotein. Mdm2 binds to p53 within its N-terminal transactivation domain, blocks
its transcriptional activity, shuttles p53 out of the nucleus, and mediates p53 degradation by
ubiquitin-protease (9-13). Since the expression of mdm2 is regulated directly by the p53
transcription factor, they form a negative autoregulatory feedback loop in quiescent cells.
Therefore, the balance between the association and the disassociation of mdm2 is a major
factor in p53 activation.
In addition to the interaction between mdm2 and p53, post-translational
modifications of p53 protein, including multiple phosphorylations and acetylations, also
play a key role in regulating p53 activity (14-16). The modifications affect several aspects
of p53 protein, such as transactivation and transrepression abilities, sequence-specific DNA
binding ability, and mdm2-p53 interaction (17-21). In response to various stimuli, several
different protein kinases are reported to phosphorylate p53 at distinct sites, such as Nterminal phosphorylation by DNA-dependent protein kinase (DNA-PK), ataxia
telangiectasia mutated (ATM) protein, mitogen-activated protein (MAP) kinase, Raf-1,
casein kinase I, C-terminal by protein kinase C (PKC), casein kinase II, cyclin-dependent
kinase (cdk), and p38 kinase (22-26). Recently, several groups reported the acetylation of
the p53 C-terminal domain by histone acetyltransferases p300, CBP (CREB binding
protein), and PCAF (p300/CBP-associated factor) (27-29). N-terminal phosphorylation is
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responsible for both enhanced transactivation activity and the dissociation of mdm2. The
modifications at the C-terminal end are associated with increased specific-sequence DNA
binding ability. Phosphorylation and acetylation events have a synergistic effect on the
activation of p53 protein.
Chromium (Cr(VI)) compounds are used widely in industry and are found in the
environment (30). Exposure to Cr(VI)-containing compounds is known to induce lung
toxicity and increased incidence of cancers of the respiratory system (31-34). Although the
mechanisms of Cr(VI)-induced carcinogenesis are not fully understood, the reactive
metabolic products of Cr(VI) including reactive oxygen species (ROS), Cr(V), and Cr(IV)
are considered to play major roles in the carcinogenic process (35-40). Previous work from
our laboratory showed that Cr(VI) activates p53 protein via hydroxyl radical-mediated
reactions (36). In the present study, we extend our investigation to elucidate the possible
mechanisms of the activation of p53 induced by Cr(VI).
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II.3.

MATERIALS AND METHODS

Materials
Sodium dichromate (Na2Cr2O7) was purchased from Aldrich (Milwaukee, WI).
Cycloheximide, actinomycin D, and p38 inhibitor (SB 202190) were purchased from
Calbiochem (La Jolla, CA). MEK1 inhibitor, PD 98059, was purchased from New England
Biolabs (Beverly, MA).
Cell culture
A human lung epithelial cell line (A549 cells) was obtained from American Type
Culture Colletion (ATCC) (Rockville, MD). The cells were maintained in a nutrient
mixture (Kaighn’s Modification) medium (F-12K) (Gibco BRL, Grand Island, NY)
supplemented with 10% fetal bovine serum (FBS), 2 mM glutamine and 1,000 units/ml
penicillin-streptomycin. The cells were cultured in 75 cm2 cell culture flasks and
trypsinized with 0.25% trypsin/EDTA for plating and passing.
Luciferase assay
Human lung epithelial A549 cells (3 × 105) suspended in 1 ml of 10% FBS F-12K
medium were seeded into each well of a 6-well plate. Following incubation at 37°C for 24
hours, the cells were transiently transfected by 1 g reporter plasmid and 1 g -gal
plasmid in reduced-serum medium. The cells were incubated overnight, washed, and fresh
10% FBS F-12K medium was added. The cells were exposed to various treatments after
and additional 24 hour culture. The cells were then extracted with 400 l reporter lysis
buffer at 4°C for 2 hours. The luciferase activity was measured with 80 l cell lysate, using
a Monolight luminometer, Model 3010 (Analytical Luminescence Laboratory, Sparks,
MD). -gal activity was determined as described previously (41). The results are expressed
as relative p53 activity compared to controls after normalizing by -gal activity.
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Western blot
The whole cell lysate were used for western blot analysis. 2 × 105 cells were
cultured in each well of 6-well plates to 95% of confluency. After treatments, the cells were
washed once with ice-cold PBS and extracted with 100 l SDS-sample buffer. The extracts
were then sonicated to shear DNA and reduce the viscosity. 20 l of the lysate was heated
to 95°C for 5 minutes and microcentrifuged for another 5 minutes. Proteins were
electrophoretically separated on 10% Tris- Glycine gels (Novex, San Diego, CA) and were
transferred to nitrocellulose membrane (Schleicher & Schuell, Keene, NH). The membrane
was treated with a blocking buffer (Tris-buffered saline Tween (TBS-T) containing 5%
non-fat milk) for 1 hour and exposed to primary antibody at 4°C overnight. The membrane
was rinsed and incubated with a 1: 2000 dilution of secondary antibody for 1 hour. The
membrane was then washed with TBS-T and antibody binding sites were visualized by
ECL western blotting detection reagents (Amersham Pharmacia Biotech, Piscataway, NJ).
P53 mouse monoclonal antibody (DO-1) and mdm2 mouse monoclonal antibody were from
Santa Cruz biotechnology (Santa Cruz, CA); phospho-p53, phospho-p38 kinase
(Thr180/Tyr182), and phospho-Erk kinase (Thr202/Tyr204) antibodies were from New
England Biolabs (Beverly, MA); and acetylated p53 (Lys382) antibody was from Oncogene
(Cambridge, MA).
Immunoprecipitation
2 × 105 cells were cultured in each well of 6-well plates to 95% of confluency. After
treatment, the cells were washed once with ice-cold PBS and collected in 100 l PBS. After
addition of 100 l 2 × reducing buffer (0.125 M Tris, pH 6.8, 20% glycerin, 2% SDS, and
10% 2-mercaptoethanol), the extracts were boiled at 95°C for 5 minutes and 500 l TNT
buffer (20 mM Tris, pH 7.4, 0.2 M NaCl, and 1% Triton 100) was added. The cell lysate,
20 l Recin/TNT (1:10), and 10 g antibody were incubated at 4°C overnight on a rotor
mixer. The Recin was spun down and washed with TNT buffer followed by boiling with 20
l reducing buffer for 5 minutes. The supernatant was collected for western blot analysis.
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II.4.

RESULTS

Cr(VI)-induced p53 activation
Human lung epithelial A549 cells were used to study induction of p53 activation by
Cr(VI). The cells were incubated with Cr(VI) at different concentrations for 3 hours. P53
protein level was analyzed in the whole cell lysates. As shown in Figure 1a, the p53 protein
level increased following exposure to Cr(VI) compared to control. Increasing the Cr(VI)
dosage did not have much effects on the p53 protein level.
Since p53 is a transcription factor, its transactivation activity can be determined by a
luciferase assay. Briefly, the cells were co-transfected with p53-luciferase reporter plasmid
and -gal plasmid, and incubated with different concentrations of Cr(VI) for 3 hours. After
washing the cells, fresh F-12K medium supplemented with 10% FBS was added. The cells
were then incubated at 37°C overnight. P53 activity was analyzed by the luciferase assay as
described in Materials and Methods. Figure 1b shows the results of the luciferase assay for
p53 activity. The p53 activity increased following exposure to Cr(VI). Increasing the
Cr(VI) concentration up to 50 M enhanced p53 activity. Increasing the Cr(VI)
concentration further resulted in a slightly lower p53 activation, possibly due to Cr(VI)induced apoptosis.
Transcription is not an important factor for p53 activation
In general, a protein level can be regulated at different levels: the transcriptional
level (mRNA), the translational level (protein synthesis), and the post-translational level
(protein modification such as phosphorylation and acetylation). To investigate whether p53
protein activation is due to an increased mRNA level, actinomycin D (AMD), a
transcription inhibitor, was used to pretreat the cells before the 3 hour incubation with
Cr(VI). As is shown from western blots, inhibition of transcription did not decrease the p53
protein level (Figure 2a, lane 3 and 6). Addition of cycloheximide (CHX), a protein
synthesis inhibitor, dramatically reduced p53 protein level (Figure 2a, lane 2 and 5). The
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results suggest that the Cr(VI)-induced increase in p53 protein level is not due to increased
transcription.
To further confirm above conclusion, a p53-promoter luciferase plasmid, which is a
measurement at the p53 gene expression level, was transiently transfected into A549 cells
(the plasmid is a generous gift from Dr. Finian Martin, University College Dublin, Ireland)
(42). The cells were then exposed to various concentrations of Cr(VI). As shown in Figure
2b, treatment with Cr(VI) did not result in an increase in p53 gene expression. The results
obtained from both western blot and luciferase assay demonstrate that p53 activation is due
to the enhanced protein synthesis, rather than increased gene expression.
Post-translational modifications are important for p53 activation by Cr(VI)
In addition to protein synthesis, protein degradation is also an important factor in
regulating the total protein level. CHX was utilized to investigate the degradation level of
p53 protein with or without Cr(VI) stimulation. A549 cells were exposed to Cr(VI) for 3
hours followed by the addition of CHX. At different time points after cessation of the
protein synthesis, whole cell lysates were collected to perform western blots. In normal
cells, the p53 half-life was approximately 1 hour. With the stimulation of Cr(VI), the
degradation of p53 protein was reduced dramatically with no significant decrease in protein
level even at 4 hour (Fig. 3), indicating enhanced stability of the p53 protein after Cr(VI)
stimulation.
It is generally believed that post-translational modifications, including
phosphorylation and acetylation, play a role in stabilizing p53 protein. With the stimulation
of Cr(VI), while the total p53 protein remained constant with the increase of Cr(VI)
concentrations, the phosphorylation of p53 on Ser 15 site exhibited a clear concentrationdependent increase (Fig. 4). Control cells had undetectable level of phosphorylation on Ser
15. With the addition of Cr(VI), the Ser 15 phosphorylation increased and peaked at the 50
M Cr(VI) exposure. The acetylation of Lys 382 at the C-terminus of p53 protein exhibited
a similar dose-dependent pattern, but with the peak at a concentration of 20 M Cr(VI). In
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contrast, the phosphorylation of the N-terminal Ser 20 and C-terminal residue Ser 392 did
not show much change in response to the stimulation with Cr(VI) (Fig. 4).
Another major factor that influences the stability of p53 protein is the binding of
p53 with mdm2. In the cytoplasm, the binding of mdm2 to the N-terminus of p53 promotes
the degradation of p53. Since we observed that the p53 degradation was reduced upon
Cr(VI) stimulation, the possible involvement of mdm2 in this process was investigated.
A549 cells were incubated with Cr(VI) for 3 hours and then collected for
immunoprecipitation by p53 antibody. The binding of mdm2 was determined by western
blot analysis. As shown in Figure 5, the binding of mdm2 to p53 dramatically decreased at
a concentration of 50 M Cr(VI) and disappeared at 100 M Cr(VI).
These results suggest that phosphorylation of Ser 15, acetylation of Lys 382, and
dissociation of mdm2 are jointly responsible for p53 activation induced by Cr(VI).
Erk is important in the phosphorylation of Ser 15
It has been reported that MAP kinase family members are involved in p53
phosphorylation induced by UV light. P38 kinase was found to phosphorylate Ser 392 of
p53 protein, and c-jun N-terminal kinase (JNK) was reported to associate with p53 directly
and stabilize the protein (26, 43). To further understand the mechanisms of p53 activation
by Cr(VI), we examined the possible roles of MAP kinase on p53 phosphorylation. Both
p38 kinase and extracellular-signal regulated kinase (Erk) can be activated by Cr(VI) in a
dose and time dependent manner (Fig. 6a). Two chemical inhibitors, PD98059 (PD), a
MEK1 inhibitor that is able to abolish Erk activity, and SB202190 (SB), a p38 kinase
inhibitor, were pre-incubated with cells followed by Cr(VI) exposure. As shown in Figure
6b, inhibition of p38 kinase activity did not have any effects on Ser 15 phosphorylation. In
contrast, inhibition of Erk significantly decreased the phosphorylation of Ser 15. In addition
to the role of Erk in phosphorylation of the p53 Ser 15 site, we examined the effects of Erk
on the p53 transactivation ability by luciferase assay. As shown in Figure 7, addition of PD
significantly reduced p53 activation induced by Cr(VI). The results suggest that Erk is
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important in the phosphorylation of p53 Ser 15 site, which plays a key role in the activation
of p53 protein by Cr(VI).
The results shown above support the importance of post-translational modifications,
including phosphorylation, acetylation, and mdm2 dissociation, in Cr(VI)-induced p53
activation. During the activation process, Erk plays a crucial role by mediating the
phosphorylation of the Ser15 site of the p53 protein.
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II.5.

DISCUSSION
The present study shows that post-translational modifications, including

phosphorylation on N-terminal, acetylation on C-terminal, and segregation of mdm2, play a
central role in p53 activation induced by Cr(VI).
Previous studies from our group have demonstrated that after exposure to Cr(VI),
p53 protein is activated at the protein level and via enhancement of both sequence-specific
DNA binding ability and transactivation ability (26). In the present study, we further
investigated the molecular mechanisms of the activation of p53. Several groups have
reported that increased mRNA expression or transcriptional activation was important for
p53 activation (44-46). In our experiments, the addition of the transcription inhibitor,
actinomycin D, did not show any inhibitory effects on p53 activation. Consistent with this
observation, the luciferase assay from cells transfected with p53 promoter-luciferase
reporter plasmid demonstrates that p53 activation by Cr(VI) was not due to transcriptional
activation.
P53 exists as a tetramer and rapidly degrades in normal cells. The degradation is
mediated by proto-oncoprotein mdm2. The prerequisite for mdm2 to promote p53
degradation is its direct binding to the N-terminal of p53 protein. In addition to mediating
p53 degradation, the binding of mdm2 blocks the transactivation ability of p53 as well.
Therefore, breaking the p53-mdm2 interaction is a major mechanism to stabilize p53. The
mdm2 protein immunoprecipitated with p53 decreased to undetectable levels with Cr(VI)
stimulation, demonstrating the dissociation of mdm2 from p53 induced by Cr(VI). The
dissociation of mdm2 may be one of the explanations for the observed dramatic reduction
of p53 degradation after Cr(VI) stimulation.
One of the factors inducing disassociation of mdm2 from p53 is the phosphorylation
of p53 protein at its N-terminal. The N-terminal phosphorylation is reported to activate the
transactivation ability of p53 (22). It is generally believed that the phosphorylation sites
close to or inside the mdm2 binding site (residues 18-23), such as Ser 15 and Ser 20, are
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capable of interfering with the association between mdm2 and p53. However, recent reports
from several groups suggest that phosphorylation of the Ser 15 site only affects p53
transactivation ability while Ser 20 phosphorylation is believed to mediate the dissociation
of mdm2 and the stabilization of p53 (47-49). In the present study, we find reduced mdm2
binding was associated with Ser 15 instead of Ser 20 phosphorylation. Therefore, it appears
that mdm2 dissociation induced by Cr(VI) is not due to the Ser 20 phosphorylation, and that
phosphorylation of other sites, such as Ser 15, may play a role in the dissociation process.
In addition to phosphorylation at the N-terminal of p53 protein, evidence is accumulating
that mdm2 can be phosphorylated by DNA-PK and ATM following stimulation with DNA
damaging reagents. These phosphorylation events have been considered to be another
important mechanism for modulating interactions between mdm2 and p53 (50, 51).
Unlike N-terminal phosphorylation, modification at C-terminal is involved in
regulating sequence-specific DNA binding ability of p53. P53 exists as a tetramer in the
cytoplasm of quiescent cells, the C-terminal acts as a negatively regulatory domain by
folding and binding to the central specific DNA binding domain of another monomer unit.
The phosphorylation and/or acetylation of the C-terminal result in the release the latent
specific DNA binding domain from the inhibitory domain. Several stimuli, including
ultraviolet (UV) radiation, tumor necrosis factor (TNF) , and anisomycin, are reported to
phosphorylate Ser 392 (Ser 389 in mouse) to activate the specific DNA binding activity of
p53 (26, 52). In the present study, Cr(VI) did not show any effects on Ser 392
phosphorylation in A549 cells. Instead, a significant acetylation at Lys 382 was observed.
This acetylation at C-terminal is likely to be responsible for the increased specific DNA
binding activity of p53 induced by Cr(VI).
Several protein kinases are capable of phosphorylating distinct sites on the p53
protein. For Ser 15 phosphorylation of p53, DNA-PK, ATM, p38, and Erk have been
reported to be the responsible kinases. However, different groups present contradictory
results. For example, p38 kinase was considered to phosphorylate Ser 392 but not Ser 15 in
response to UV radiation (53). In contrast, another group reported that upon stimulation by
UV light, p38 kinase was responsible for the phosphorylation of the Ser 15 site (54). The
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different effects of upstream kinases in phosphorylating the same sites might be due to
different cellular environments. In our investigation, the results obtained demonstrate that
instead of p38 kinase, Erk is involved in the phosphorylation of Ser 15.
Although Cr(VI) is a well established carcinogen, the mechanisms of its
carcinogenesis are not fully understood. It is well established that p53 plays an important
role in carcinogenesis. The two major functions of p53 protein are cell cycle arrest and
apoptosis, which are responsible for repairing or removing the damaged cells. Since these
two processes have a crucial role in protecting cells from permanent genetic damage, which
is mediated by p53, alternations in these pathways can contribute to cancer development.
Therefore, understanding the mechanisms of p53 activation is essential for understanding
the overall carcinogenic process induced not only by Cr(VI), but also by other chemical and
particle carcinogens as well.
In conclusion, in the process of p53 activation induced by Cr(VI), post-translational
modifications, including Ser 15 phosphorylation, Lys 382 acetylation, and mdm2
dissociation, play crucial roles. Erk, but not p38 kinase, is responsible for the
phosphorylation of Ser 15 induced by Cr(VI).
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FIGURES
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Fig. 1 p53 activation induced by Cr(VI). (a) Western blot of p53 protein level. Human
lung epithelial A549 cells were treated with various concentrations of Cr(VI) for 3
hours. The cells were then collected for the whole cell lysates. The p53 protein
levels were determined by western blot, using specific antibodies for p53 protein.
(b) Luciferase assay for Cr(VI)-induced p53 activation. A549 cells were transiently
transfected with a p53-luciferase reporter plasmid and a -gal plasmid in reducedserum medium. The cells were incubated overnight, washed, added to fresh 10%
FBS F-12K medium, and incubated for 24 hours. The cells were exposed to Cr(VI)
at various concentrations for 3 hours, washed, added to fresh F-12K medium, and
incubated overnight. The p53 activity was measured by luciferase activity assay as
described in the Materials and Methods. Results are presented as relative p53
induction compared to the untreated control cells (means and standard deviation of
three separated experiments). Asterisks indicate a significant increase from control
(p < 0.05).
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Fig. 2 Transcription is not a major factor for p53 activation. (a) A549 cells were
pretreated with 10 g/ml cycloheximide (CHX) or 1 g/ml actinomycin D (AMD)
for 30 minutes, followed by incubation with or without 50 M Cr(VI) for 3 hours.
The whole cell lysates were collected for western blot analysis, using a specific p53
antibody. (b) Luciferase assay for p53 promoter activity. A549 cells were transiently
transfected with p53-promoter luciferase plasmid. Then the cells were exposed to
various concentrations of Cr(VI) for 3 hours, washed, added to fresh F-12K
medium, and incubated overnight. The p53 activity was measured by the luciferase
activity assay. UVC light was used as a positive control. Results are presented as
relative p53 promoter induction compared to the untreated control cells (means and
standard deviation of three separated assays). Asterisks indicate a significant
increase from control (p < 0.05).
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Fig. 3 p53 degradation is reduced with Cr(VI) stimulation. A549 cells were incubated
with or without 50 M Cr(VI) for 3 hours, followed by the addition of 10 g/ml
CHX. The whole cell lysates were collected at different time points after treatment
with CHX. Western blot analysis was performed using a specific p53 antibody. (a)
shows the results from western blot. (b) indicates the percentage of p53 protein level
at different times based on the quantitation of (a).
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Fig. 4 Phosphorylation and acetylation of p53 induced by Cr(VI). A549 cells were
incubated with various concentrations of Cr(VI) for 3 hours. The whole cell lysates
were collected for western blot analysis using specific antibodies for p53 protein,
Ser 15 and Ser 392 phospho-p53, and Lys 382 acetylated p53 protein, respectively.
UVC light was used as a positive control.
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Fig. 5 Dissociation of mdm2 induced by Cr(VI). A549 cells were incubated with various
concentrations of Cr(VI) for 3 hours, followed by immunoprecipitation with a
specific p53 antibody. Western blot analysis was performed, using a specific
antibody for mdm2 protein.
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Fig. 6 Erk is involved in Ser 15 phosphorylation of p53. (a) Activation of p38 and Erk
with Cr(VI) stimulation. A549 cells were incubated with various concentrations of
Cr(VI) for various time as indicated. The whole cell lysates were collected for
western blot using specific antibodies for phospho-p38 and phospho-Erk,
respectively. (b) Inhibition of Erk reduces Ser 15 phosphorylation. A549 cells were
pretreated with p38 inhibitor SB202190 or MEK1 inhibitor PD98059 for 30
minutes, followed by incubation with or without 50 M Cr(VI) for 3 hours. The
whole cell lysates were collected for western blot, using specific antibody for
phospho- Ser 15 p53 antibody. (c) Quantitation of (b). * indicates a significant
increase from lane 1; + indicates a significant decrease from lane 2.
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Fig. 7 Inhibition of Erk decreases Cr(VI)-induced p53 activation. A549 cells were
transient transfected with p53 luciferase plasmid. Then the cells were pretreated
with PD, followed by exposure to 50 M Cr(VI) for 3 hours. The cells were
washed, added to fresh F-12K medium, and incubated overnight. The p53 activity
was measured by luciferase activity assay. Results are presented as relative p53
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deviation of three repeated assays). Asterisks indicate a significant increase from
control, and double asterisks indicate a significant decrease from the induction level
(p < 0.05).
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SECTION III
Role of NF-6
6B in protecting cells from Cr(VI)-induced apoptosis
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III.1.

ABSTRACT
The tumor suppressor protein p53 protects cells against tumorgenesis by causing

cell growth arrest or apoptosis. The transcription factor NF-κB has been reported to prevent
cells from undergoing apoptosis as well as to enhance apoptosis. To investigate the role of
NF-κB in Cr(VI)-induced apoptosis and the possible involvement of p53, two cell lines
were developed from human bronchial epithelial BEAS-2B cells: IKK cells, which were
stably transfected with IκB expression vector, that have normal NF-κB activity, and KM
cells, which were stably transfected with mutated IκB kinase expression vector, that
exhibit very little NF-κB activity. With Cr(VI) stimulation, KM cells underwent greater
apoptosis than IKK cells. Concomitantly, both p53 protein level and N-terminal
phosphorylation were increased in KM cells but not in IKK cells after Cr(VI) treatment.
The results suggest that NF-κB activation is required to prevent the cells from undergoing
Cr(VI)-induced apoptosis. This blockade is mediated through the inhibition of p53 protein
activation, primarily by abolishing the N-terminal phosphorylations induced by Cr(VI).
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III.2.

INTRODUCTION
The p53 tumor suppressor protein protects cells against tumorgenesis by inducing

cell growth arrest or apoptosis (27,30). A variety of mutations in the p53 gene and
inactivation or abnormality of p53 protein have been identified in various cancers in both
humans and experimental animals, suggesting a crucial role of p53 protein in preventing
tumorgenesis (22,30). Wild type p53 has a very short half-life and low protein levels are
seen in normal cells (3). In response to stimuli, such as UV, gamma radiation, hypoxia,
nucleotide deprivation, and metal ions, an increase in half-life and a rapid accumulation of
p53 protein were observed (14,16,25,31,48). Binding of murine double minute-2 (mdm2)
proto-oncoprotein and posttranslational modifications of p53 protein, including multiple
phosphorylations and acetylations, are considered to be two major factors to regulate p53
activation (32-34). Mdm2 binds to p53 within its N-terminal transactivation domain, blocks
its transcriptional activity, shuttles p53 out of the nucleus, and mediates p53 degradation by
ubiquitin-protease (11,12,15,18,28). By contrast, the posttranslational modifications
function to stabilize and activate p53. The modifications are capable of modulating several
aspects of p53 protein, such as transactivation and transrepression, sequence-specific DNA
binding, and mdm2-p53 interaction (17,20,23,35,43). In response to stimuli, different sites
of p53 protein become phosphorylated and acetylated by distinct kinases, depending on the
nature of the stimulant and the cellular environment. Generally, N-terminal phosphorylation
is responsible for both enhanced transactivation activity and the disassociation of mdm2.
The modifications on the C-terminal end are associated with increased specific-sequence
DNA binding ability. Phosphorylation and acetylation of different sites synergistically
contribute to the activation of p53 protein (45).
The nuclear transcription factor NF-κB plays a crucial role in cell survival and
proliferation as well as immune responses by regulating the expression of a variety of genes
(1,2,5,24). In unstimulated cells, NF-κB protein exists in an inactive form in the cytoplasm
bound to inhibitor proteins belonging to IκB family, which inhibit activation, translocation,
and DNA binding activity of NF-κB. Among IκB family members, IκB is the most
abundant and best investigated inhibitor. Once stimulated, IκB is phosphorylated

67

primarily by IκB kinases. The phosphorylated IκB is then ubiquitinated and rapidly
degraded by a number of proteolytic enzymes (5). The degradation of IκB releases the
activated NF-κB, which translocates into the nucleus and regulates the transcription of its
target genes.
Unlike p53, NF-κB functions as a pro- or anti-apoptotic mediator depending on the
nature of stimuli and the cellular systems (10). A number of stimuli are reported to activate
both NF-κB and p53, suggesting the possible interaction of these two signal transduction
pathways. Recent evidence demonstrates the existence of cross talk between NF-κB and
p53. However, the relationship between these two transcription factors is not fully
understood. In the present study, two stable transfected cell lines, IKK, which has normal
NF-κB activity, and KM, in which NF-κB activity is nearly completely abolished, were
developed from the human bronchial epithelial cell line, BEAS-2B, and the role of NF-κB
in Cr(VI)-induced p53 activation was investigated.
Chromium (Cr(VI)) compounds are established carcinogens. Both industrial and
environmental exposures to Cr(VI) have been associated with an increased incidence of
cancers in the respiratory system (8,13,19,29,44). Although the mechanisms of Cr(VI)induced carcinogenesis are not fully understood, reactive oxygen species (ROS), Cr(V), and
Cr(IV), which are generated during the reduction process of Cr(VI), are considered to be
responsible for the carcinogenesis of these compounds (39-42,47,53). Previous studies from
our laboratory have shown that Cr(VI) is able to activate p53 protein in human lung
epithelial cells via hydroxyl radical-mediated reactions (47). In this study, we used Cr(VI)
as a stimulator for p53 activation, and utilized the two cell lines described above to
investigate the role of NF-κB in Cr(VI)-induced apoptosis and the possible involvement of
p53.
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III.3.

MATERIALS AND METHODS

Cells and Reagents
The human bronchial epithelial cell line, BEAS-2B, was obtained from American
Type Culture Collection (ATCC) (Rockville, MD). The cells were cultured in DMEM
media (Sigma Chemical Company, St. Louis, MO) supplemented with 5% fetal bovine
serum (FBS), 2 mM glutamine and 1,000 units/ml penicillin-streptomycin. Sodium
dichromate (Na2Cr2O7) was purchased from Aldrich (Milwaukee, WI). The luciferase assay
kit was from Promega (Madison, WI). P53 and phospho-IκB antibodies were from Santa
Cruz Biotechnology (Santa Cruz, CA). Phospho-p53 antibodies for specific sites were from
New England Biolabs (Beverly, MA).
Cell Transfection
pCR-Flag-IKK and pCR-Flag-IKK -KM (K44A) were gifts from Dr. Hiroyasu
Nakano (Juntendo University, Tokyo, Japan). BEAS-2B cells were plated in 6-well plates
at 5 × 105 cells/well and incubated for two days. The cells were then transfected with
indicated expression vectors along with a 3 × κB-dependent luciferase reporter construct
using Lipofectamine (Life Technologies, Rockville, MD) as described previously (6). All
individual clone of BEAS-2B cells, stably transfected with the expression vectors of either
IKK or IKK -KM together with luciferase reporter genes, was isolated after incubation
with 700 g/ml of G418 for three weeks. The cells were then tested by western blotting and
luciferase assays for expression of the transfected genes. Stably transfected cells were
maintained in regular culture media supplemented with 200 g/ml of G418.
Nuclear extraction
Nuclear extracts were prepared by a modified method of Chen, et al (7).
The cells were cultured in 35 mm cell culture plates at 5 × 106 cells/plate for 24 hours. The
cells were incubated with 10 g/ml LPS for different time points. At the end of the culture
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period, cells were harvested and treated with 500 l lysis buffer (50 mM KCl, 0.5% NP-40,
25 mM HEPES pH 7.8, 1 mM phenylmethylsulfonyl fluoride (PMSF), 10 g/ml leupeptin,
20 g/ml aprotinin, and 100 M DTT) on ice for 4 minutes. After centrifugation at 14,000
rpm for 1 minute, the supernatant was saved as a cytoplasmic extract. The nuclei were
washed once with the same buffer without NP-40. The washed nuclei were suspended in a
100 l volume of extraction buffer (500 mM KCl, 10% glycerol with the same
concentrations of HEPES, PMSF, leupeptin, aprotinin and DTT as the lysis buffer), and
pipetted three times for proper mixing. After centrifugation at 14,000 rpm for 5 minutes, the
supernatant was harvested and this nuclear protein extract was stored at -70°C. The
concentration was determined using a BCA protein assay reagent (Pierce, Rockford, IL).
Oligonucleotide
Oligonucleotides were synthesized by the phosphoramidite method on a DNA/RNA
Synthesizer (Applied Biosystems, Model 392, Foster City, CA). A NF-κB binding
sequence (5’GAAATTCCAAAGAGTCATCAGA3’) from the promotor region of the
human IL-2 receptor α chain gene was used to synthesize a NF-κB binding oligonucleotide.
The synthesized single-stranded oligonucleotides were deprotected at 50°C overnight, dried
in a speed vacuum and then dissolved in the Tris-EDTA buffer. Complimentary strands
were denatured at 80°C for 5 min and annealed at room temperature. The double-stranded
probe was labeled with 32P-dCTP (Amersham, Arlington Heights, IL) using a Klenow
fragment (Bethesda Research Laboratories, Gaithersburg, MD).
Electrophoretic mobility shift assay (EMSA)
The DNA-protein binding reaction was conducted in a 24 µl reaction mixture
including 1 µg Poly dI.dC, (Sigma, St. Louis, MO), 4 µg nuclear protein extract, 3 µg BSA,
4 × 104 cpm of 32P-labeled oligonucleotide probe (1 µg), 3 µl distilled water and 12 µl of 2
× anneal buffer (24% glycerol, 24 mM HEPES pH 7.9, 8 mM Tris-HCl pH 7.9, 2 mM
EDTA, 2 mM DTT). This mixture was incubated on ice for 10 min in the absence of the

70

radiolabelled probe, and then incubated for 20 min at room temperature in the presence of
radiolabelled probe. After the incubation, the DNA-protein complexes were resolved on a
5% acrylamide gel (National Diagnostics, Atlanta, GA) that had been pre-run at 210 V for
30 min with 0.5 × Tris-boric acid-EDTA buffer. The loaded gel was run at 210 V for 90
min, then dried and placed on Kodak X-OMAT film (Eastman Kodak, Rochester, NY) for
autoradiography. The film was developed after overnight exposure at –70°C.
The concentrations given in the figure legends are final concentrations. All
experiments were performed at room temperature and under ambient air except those
specifically indicated.
Luciferase assay
The stably transfected cells (5 × 104) suspended in 1 ml of 5% FBS DMEM medium
were seeded into each well of a 24-well plate. After incubation at 37°C for 24 hours, the
cells were exposed to various concentrations of Cr(VI). The cells were then extracted with
100 l lysis buffer in 4°C for 30 minutes. The luciferase activity was measured with 20 l
cell lysate, using a Monolight luminometer, Model 3010 (Analytical Luminescence
Laboratory, Sparks, MD). The results are expressed as relative NF-κB activity compared to
controls.
Western blot
The whole cell lysates were used for western blot analysis. 2 × 105 cells were
cultured in each well of 6-well plates to 95% of confluency. After treatments, the cells were
washed once with ice-cold PBS and extracted with 100 l SDS-sample buffer. The extracts
were then sonicated to shear DNA and reduce the viscosity. 20 l of the lysates was heated
to 95°C for 5 minutes and microcentrifuged for another 5 minutes. Proteins were
electrophoretically separated on 10% Tris- Glycine gels (Novex, San Diego, CA) and were
transferred to nitrocellulose membrane (Schleicher & Schuell, Keene, NH). The membrane
was treated with a blocking buffer (Tris-buffered saline Tween (TBS-T) containing 5%
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non-fat milk) for 1 hour and exposed to primary antibody at 4°C overnight. The membrane
was rinsed and incubated with a 1: 2000 dilution of secondary antibody for 1 hour. The
membrane was then washed with TBS-T and antibody binding sites were visualized by
ECL western blotting detection reagents (Amersham Pharmacia Biotech, Piscataway, NJ).
P53 and mdm2 antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA),
phospho-p53 and phospho-MAP kinase antibodies were from New England Biolabs
(Beverly, MA), and acetylated p53 antibody was from Oncogene (Cambridge, MA).
TUNEL assay for apoptosis
DNA fragmentation in apoptosis was determined by TUNEL assay. The experiment
was conducted as reported earlier (38) with minor modifications. The cells were cultured in
35 mm cell culture plates at 5 × 106 cells/plate for 24 hours. After treatment with 20 M
Cr(VI) for 36 hours, the cells were washed once with ice-cold PBS and collected in 0.5 ml
PBS. After washing once with PBS containing 1% BSA, the cells were resuspended in PBS
at the concentration of 1 × 107 cells/ml. 100 l of cell suspension (about 1 × 106 cells) was
transferred into an Eppendorf tube and the cells were fixed with the addition of 100 l of
paraformaldehyde (4% in PBS, pH 7.4). After mixing well and incubating at room
temperature for 30 minutes, the cells were washed twice with PBS and resuspended in 100
l permeabilisation solution (0.1% Triton X-100 and 0.1% sodium citrate). The suspension
was kept on ice for 5 minutes and washed twice with 200 l PBS. The cells were then
resuspended in 50 l reaction solution and incubated in a humidified dark chamber at 37°C
for 1 hour. After washing twice with PBS, the cells were transferred into a tube to a final
volume of 500 l in PBS and analyzed by flow cytometry. At least 10,000 cells were
collected in each group. The cells undergoing apoptosis were indicated by the percentage.
The peak shift indicates that more cells are going apoptosis.
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III.4.

RESULTS

NF-κ
κB activity is abolished in KM cells
IKK cells were developed from BEAS-2B cells by stable transfection of IκB kinase
expression vector, and KM cells were stably transfected with mutated IκB kinase
expression vector, in which the mutant protein lacks the kinase activity. After transfection,
the phosphorylation level of IκB and the NF-κB activity of the two cell lines were
examined using LPS as a stimulant. In IKK cells, IκB became phosphorylated after 15
minutes of LPS treatment (Fig. 1a, lane 2). The phosphorylation increased with time (Fig.
1a, lanes 1-5). In contrast, the phosphorylation of IκB did not show appreciable changes in
KM cells following the stimulation with LPS (Fig. 1a, lanes 6-10). Concomitant with the
increase in IκB phosphorylation, a time-dependent increase in specific DNA binding
activity of NF-κB was observed in IKK cells after LPS treatment (Fig. 1b, lanes 1-5), but
not in KM cells (Fig. 1b, lanes 6-10).
Cr(VI)-induced NF-κ
κB activation in IKK cells but not in KM cells
The above results indicate that LPS induced-NF-κB activation was abolished in KM
cells. To demonstrate the effects of Cr(VI) on IKK and KM cells, these two cells were
incubated with Cr(VI) at various concentrations for 24 hours. The luciferase levels, which
measure the relative NF-κB activity, were determined by a luciferase assay as described in
Materials and Methods. In IKK cells, NF-κB was dramatically activated (around 20 fold
increase) by Cr(VI) at approximately 8 M, and became inactive at around 30 M. In
contrast, NF-κB activity was unchanged in KM cells treated with Cr(VI) (Fig. 2).
NF-6
6B activation is required to protect cells from Cr(VI)-induced apoptosis
Incubation with Cr(VI) induced greater cell death in KM cells compared to IKK
cells. Since previous work from our group has demonstrated that Cr(VI) is able to induce
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apoptosis (52), we hypothesized that the cell death is due to apoptosis. To verify this
assumption, apoptosis assay was carried out in these two types of cells following treatment
with Cr(VI). The cells were incubated with 20 M Cr(VI) for 36 hours and apoptosis was
measured by the TUNEL assay. As shown in Fig. 3, following treatment with Cr(VI),
apoptosis level of KM cells increased by 30%, while IKK cells did not show any increase
on apoptosis when stimulated with Cr(VI). The results confirm that NF-κB defective cells
exhibited greater Cr(VI)-induced apoptosis than normal cells, suggesting that NF-κB
activation prevents the cells from undergoing apoptosis.
NF-κ
κB inactivation promotes p53 phosphorylation and activation
It is generally believed that p53 protein plays a crucial role in mediating apoptosis.
To further investigate the mechanisms of NF-κB activation in preventing cells from
apoptosis, the possible involvement of p53 was examined. The increase in Cr(VI)-induced
apoptosis was associated with a dose-dependent increase in p53 protein levels in KM cells.
In contrast, the p53 protein level in IKK cells did not exhibit significant alteration following
Cr(VI) exposure (Fig. 4). Since posttranslational modifications are major mechanisms for
p53 activation, the phosphorylation of p53 protein in these two cell lines was examined
using specific antibodies for each phosphorylation site. The phosphorylation of p53 on Nterminal Ser 20 and Ser 15 sites in KM cells exhibited a clear concentration-dependent
increase following Cr(VI) exposure. In contrast, no Cr(VI)-induced phosphorylation was
detected in IKK cells (Fig. 5). There was no increase in phosphorylation of C-terminal Ser
392 in response to Cr(VI) in either KM or IKK cells. The results demonstrate that
deficiency of NF-κB activation enhanced the N-terminal phosphorylation of p53 protein,
which is considered to play a crucial role in stabilizing and activating this protein.
The results shown above support the importance of NF-κB in preventing cells from
undergoing apoptosis in response to Cr(VI) stimulation. This blockade is mediated through
the inhibition of p53 protein activation, primarily by abolishing the N-terminal
phosphorylation induced by Cr(VI).
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III.5.

DISCUSSION
The present studies demonstrate that activation of p53 induced by Cr(VI) is due to

inhibition of NF-κB. Inactivation of NF-κB results in phosphorylation at the N-terminal end
of p53 protein and a consequent increase in p53 protein level.
NF-κB is a transcription factor that mediates numerous cellular responses primarily
by upregulating the expressions of its target genes. In addition to its traditional role in cell
survival and proliferation, NF-κB has been reported to be involved in regulating apoptosis.
However, different roles of NF-κB in apoptosis, either pro- or anti-apoptotic, have been
reported (10). NF-κB activated by signals from death receptors was found to prevent
apoptosis, while activation of NF-κB enhances apoptosis signals in other circumstances
(10). In the present study, cells with a deficiency in NF-κB activation (KM cells) were
observed to be more sensitive to Cr(VI)-induced apoptosis, suggesting an anti-apoptotic
role of NF-kB in this system. Although the mechanisms of Cr(VI) induced apoptosis are not
fully understood, p53 and reactive oxygen species (ROS) generated during cellular
reduction of Cr(VI) have been suggested to play major roles in mediating programmed cell
death (52). It may be noted that while death receptors-mediated NF-κB activation prevents
apoptosis, there has been no previous report showing the involvement of death receptors in
Cr(VI)-induced apoptosis. It is likely that there are two possible explanations for the antiapoptotic role of NF-κB activation in apoptosis induced by Cr(VI): A) in addition to p53
and ROS, death receptors are also involved in Cr(VI)-induced apoptosis; or B) the antiapoptotic role of NF-κB activation is not limited to signaling from death receptors. Further
investigation is required to fully understand the possible mechanisms.
Since p53 has been reported to play a very important role in Cr(VI)-induced
apoptosis, we further investigated the possible involvement of this tumor suppressor
transcription factor in the anti-apoptotic effect of NF-κB activation in Cr(VI)-induced
apoptosis. The effects of NF-κB on p53 activation have been investigated at different
levels. Several groups have reported that NF-κB is capable of upregualting the gene
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expression of p53 (21,26,36,50,51). It has been reported that there is a κB site, which is
responsible for sequence-specific NF-κB binding, in the promoter region of the p53 gene.
NF-κB is able to activate the expression of the p53 gene by binding to the κB site in
response to stimuli, including tumor necrosis factor (TNF) , anticancer drugs,
environmental carcinogens, and ionizing radiation (21,26,36,50,51). However, in addition
to the increased gene expression level, other interactions between NF-κB and p53 have
been presented by several other groups (37,49). It has been reported that NF-κB and p53
inhibit each other’s ability to stimulate gene expression by competing for the same
transcriptional coactivator proteins, p300 and CREB-binding protein (CBP) (49).
Activation of NF-κB has been shown to be required for the inactivation of p53 in response
to viral exposure (37). In the present study, we found that inactivation of NF-κB was
responsible for the N-terminal Ser 15 and Ser 20 phosphorylation of p53 protein. The
phosphorylation of Ser 15 and Ser 20 sites is believed to be responsible for the stabilization
and increased transactivation ability of p53 protein (4,9,45,46). The phosphorylation and
subsequent activation of p53 in NF-κB inactivated (KM) cells at least partially explain the
enhanced apoptosis following exposure to Cr(VI).
The differences in p53 phosphorylation and protein levels in IKK and KM cells
were observed after overnight incubation of these two types of cells with Cr(VI). At earlier
time points, such as 3 hour and 6 hour, both cells were found to have similar increased
levels of phosphorylation of p53 protein, suggesting that NF-κB activation regulates p53
activation indirectly through its downstream effectors, probably by modulating the
upstream kinases for p53 phosphorylation.
Although Cr(VI) is a well established carcinogen, the mechanisms of carcinogenesis
due to Cr(VI) are not fully understood. It is generally believed that p53 plays an important
role in carcinogenesis. Regulation of cell cycle arrest and apoptosis, which are responsible
for repairing or removing damaged cells, is an important function of p53 protein. Since
these two processes play a crucial role in protecting cells from permanent genetic damage,
alteration of these p53 dependent pathways can contribute to cancer development. The
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results from the present studies indicate that NF-κB activation is capable of diminishing
Cr(VI)-induced p53 activation, and preventing cells from undergoing apoptosis. It is
possible that NF-κB may play a key role in apoptosis induced not only by Cr(VI), but also
by other chemical and particle carcinogens as well. This is an area for further investigation.
In conclusion, NF-κB activation prevents Cr(VI)-induced apoptosis by inhibiting
the phosphorylation and further activation of p53 protein.
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Fig. 1 NF-κ
κB activity is abolished in KM cells. (a) Western blot for IκB
phosphorylation. 2 × 105 IKK or KM cells were cultured in each well of 6-well
plates to 95% of confluency. After incubation with 10 g/ml LPS for different
times, the cells were collected for the whole cell lysates. The phosphorylation of
IκB was determined by western blot, using specific antibodies for phospho-IκB
protein. (b) Electrophoretic mobility shift assay (EMSA) for NF-κB specific DNA
binding activity. The cells were cultured in 35 mm cell culture plates at 5 × 106
cells/plate for 24 hours and then incubated with 10 g/ml LPS for different time
points. At the end of the culture period, cells were harvested and the nuclear
extractions were collected. DNA binding activity of the NF-κB protein was detected
with a probe of 32P labeled double-stranded NF-κB binding oligonucleotide by an
EMSA assay. The results are representatives of three separated experiments.
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Fig. 2 Cr(VI)-induced NF-κ
κB activation in IKK cells but not in KM cells. The stably
transfected cells (5 × 104) suspended in 1 ml of 5% FBS DMEM medium were
seeded into each well of a 24-well plate. After being incubated at 37°C for 24 hours,
the cells were exposed to various concentrations of Cr(VI) for 24 hours. The NF-κB
activity was measured by luciferase activity assay. Results are presented as relative
NF-κB induction compared to the untreated control cells. The results are the mean ±
SEM of three separate experiments. * indicates a significant increase above control
(p < 0.05).
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Fig. 3 NF-6
6B activation is required to protect cells from Cr(VI)-induced apoptosis.
The cells were cultured in 35 mm cell culture plates at 5 × 106 cells/plate for 24
hours. After treatment with 20 M Cr(VI) for 36 hours, the cells were collected for
apoptosis assay. Apoptosis was measured by TUNEL assay as described in
Materials and Methods. The results are representatives of three separated
experiments.
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Fig. 4 Increase of p53 protein level in KM cells following Cr(VI) stimulation. IKK and
KM cells were incubated with various concentrations of Cr(VI) overnight. The
whole cell lysates were collected for western blot using specific antibodies for p53
protein. The results are representatives of three separated experiments.
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Fig. 5 N-terminal phosphorylation of p53 protein in KM cells. IKK and KM cells were
incubated with various concentrations of Cr(VI) overnight. The whole cell lysates
were collected for western blot using specific antibodies for phospho-p53 on Ser 20,
Ser 15, and Ser 392, respectively. The results are representatives of three separated
experiments.
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SECTION IV
Role of reactive oxygen species and Cr(VI) in Ras mediated signal
transduction
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IV.1. ABSTRACT
Previous studies have shown that a constitutively active isoform of Ras is able to
produce superoxide radical (O2 -). The present studies investigate the mechanisms by which
O2 - radical mediates signals from Ras protein to the nucleus, leading to cellular responses
such as apoptosis in Cr(VI)-stimulated cells. Two human prostate tumor cell lines, Ras(+),
which overexpresses Ras, and Ras(-), which has a normal Ras level, were utilized.
Compared to Ras(-) cells, Ras(+) cells exhibited higher susceptibility to apoptosis induced
by Cr(VI). Catalase, sodium formate, and deferoxamine inhibited Cr(VI)-induced
apoptosis. Similar differences were observed in both cellular DNA damage and the
activation of p53 protein. The differences in Cr(VI)-induced cell responses in Ras(+) and
Ras(-) cells were due to differences in the generation of free radicals between these two
cells. Upon stimulation with Cr(VI), Ras(+) cells generated more O2 - than Ras(-) cells as
demonstrated by a fluorescence assay. ESR spin trapping measurements showed that Ras(+)
cells generated more hydroxyl radical (COH), O2 - radical, and Cr(V) than Ras(-) cells
following Cr(VI) stimulation. The generation of the reactive oxygen species can be
abolished by the addition of superoxide dismutase (SOD) or if the experiment were carried
out in an argon atmosphere. Catalase also inhibited spin adduct signals but much less
potently than SOD. The mechanism of ROS generation in Cr(VI)-stimulated Ras(+) cells
involves the reduction of molecular oxygen to O2 - radical by a flavoenzyme-containing
NADPH oxidase complex as shown by oxygen consumption and diphenylene iodonium
(DPI) inhibition. Results shown above support the following conclusions: a) Ras protein
mediates O2 - radical generation through reduction of molecular oxygen by NADPH oxidase
in Cr(VI)-stimulated cells. b) The O2 - radical and Cr(VI) produce other reactive species,
including H2O2, COH radical, and Cr(V) through O2 - dismutation and Haber-Weiss type of
reactions. c) Among these reactive species, COH radical is responsible for the further
transduction of signals from Ras to the nucleus, leading to various cell responses.
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IV.2. INTRODUCTION
Reactive oxygen species (ROS) have been traditionally considered to be involved in
the pathogenesis of various diseases and carcinogenesis (1-5). ROS include, but not limited
to, superoxide radical (O2 -), hydrogen peroxide (H2O2), and hydroxyl radical (COH). In
cellular system, some of these species are generated by phagocytes and play an active role
in immunological host defense (6,7). The ROS are essential for the normal killing of
ingested microbes. In addition, recent studies suggest that ROS act as intracellular second
messengers in regulating normal cell functions. ROS have been reported to activate a
variety of transcription factors and signal proteins, including NF-6B, AP-1, c-fos, tumor
suppressor protein p53, and protein kinase C (PKC) (8-12). However, an excessive
production of ROS may cause damage to the cellular components, such as lipid
peroxidation, membrane injury, and DNA damage including strand breaks and base
modification (1, 2, 13-18). By inducing DNA damage and abnormal activation of certain
cell growth regulators, ROS are considered to contribute to the carcinogenic process (2, 18,
19).
Many metals and metal-containing particles, such as chromium (Cr(VI)), nickel,
cobalt, cadmium, and silica, are known carcinogens. Although the mechanisms of their
carcinogenesis are not clear yet, it is generally believed that ROS play a crucial role. Since
many metals and particles follow similar mechanisms for ROS generation and subsequent
cellular responses, Cr(VI) was utilized in the present study.
Cr(VI)-containing compounds are well established carcinogens (20). Exposure to
these compounds has been associated with lung toxicity and increased incidence of human
lung cancer (21-23). Recent studies have shown that after entering the cell through anion
transport system, Cr(VI) is able to generate a whole spectrum of ROS (11, 24-29). The ROS
can cause DNA strand breaks, base modification, lipid peroxidation, and activation of
nuclear transcription factor NF-kB and tumor suppress protein p53 (1, 11, 27-31).
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The Ras p21 protein, a member of Ras superfamily of small GTP-binding proteins,
has important regulatory roles in the control of signal transduction, cell proliferation, and
differentiation (32-35). The mutationally activated Ras genes have been found in a variety
of human cancers and experimental animals (36, 37). Recently, it has been reported that
overexpression of Ras protein generates O2 - radical (38). This radical is involved in Ras
signal transduction to the nucleus, mediating Ras-induced cell cycle progression,
independent of mitogen-activated protein kinase (MAPK) pathway. These findings add to
the growing evidence that O2 - radical can play a role in the cell signaling pathways. These
studies also implicate O2 - radical in the Ras signaling pathway, which plays a key role in
cell growth modulation. However, the mechanisms of how O2 - radical carries the Ras
signal to the nucleus is still unclear. It is known that O2 - radical exhibits a very low
reactivity by itself. It appears that O2 - radical is not capable of directly transducing the Ras
signals to nucleus, other more reactive intermediates must be involved in this signal
transduction process.
In our previous studies, we have demonstrated that cellular reduction of Cr(VI) is
able to generate a whole spectrum of ROS (26, 39). Among Cr(VI)-generated ROS, COH
radical is the species which causes the DNA damage and other cellular injuries (26). It has
been reported that COH radical functions as a second messenger in the activation of both
NF-6B and p53 protein (11, 40). Based on these previous studies, we hypothesize that O2 radical, which is produced from overexpressed Ras protein under Cr(VI) stimulation, reacts
with Cr(VI) to generate COH radical by Haber-Weiss cycle. It is the COH radical that is
responsible for transmitting signals from Ras protein to the nucleus.
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IV.3. MATERIALS AND METHODS
Materials
Sodium dichromate (Na2Cr2O7) was purchased from Aldrich (Milwaukee, WI).
Deferoxamine, 5,5-dimethyl-1-pyrroline N-oxide (DMPO), superoxide dismutase (SOD),
catalase, sodium formate, hydrogen peroxide, diphenylene iodonium (DPI), and rotenone
were purchased from Sigma (St. Louis, MO). Dihydroethidium was purchased from
Molecular Probes (Eugene, OR). The spin trap, DMPO, was purified by charcoal
decolorization and vacuum distillation and was free of ESR detectable impurities.
Cell lines and cell culture
The human prostate tumor cell line, LNCap (ATCC, CRL-1740) (Ras (-)), was
obtained from American Type Culture Collection (ATCC) (Rockville, MD). Ras(+) cells,
which constantly overexpress Ras protein, were developed by transfecting LNCap cells
with the H-ras expression vector. The cells were cultured at 37 °C in a 5% CO2 incubator
with RPMI 1640 cell culture medium supplemented with 5% fetal bovine serum (FBS), 2
mM glutamine, 2 mM HEPES, and 0.075% Na2HCO3 (pH 7.4). The cells were cultured in
75 cm2 cell culture flasks and trypsinized with 0.25% trypsin EDTA for plating and
passing.
Apoptosis assay
The cells were plated in a 96-well plate at a density of 2 × 104 cells/well in
supplemented RPMI 1640 and incubated for 16 hours before the cells were subjected to
treatment in triplicate wells. After treatment, the cells were washed twice in phosphatebuffered saline (PBS). Apoptosis was measured by quantitating the levels of cytosolic
histone-bound DNA fragments, using a cell death enzyme-linked immunosorbent assay
(ELISA) kit (Roche Molecular Biochemicals, IN). The assays were carried out according to
the protocol provided by the manufacturer. Briefly, the cells were lysed with 200 l lysis
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buffer at room temperature. The lysates from three identical wells were combined, and 20
l mixed lysates was mixed with 80 l antibody solution in a well of the ELISA plate. The
loaded wells were incubated at room temperature for 2 hours, and then washed three times
by washing buffer. After adding the substrate and incubating the cells at 37°C for 10-20
minutes, the reaction was terminated. The optical density of each well was measured using
a microplate reader at a wavelength of 405 nm. The readings represent the degree of
apoptosis. A mean value of three separate experiments was used for analysis.
Western blot
The whole cell lysates were used for western blot analysis. 2 × 105 cells were
cultured in each well of 6-well plates to 95% of confluency. After treatments, the cells were
washed once with ice-cold PBS and extracted with 100 l SDS-sample buffer. The extracts
were then sonicated to shear DNA and reduce the viscosity. 20 l of the lysates was heated
to 95°C for 5 minutes and microcentrifuged for another 5 minutes. Proteins were
electrophoretically separated on 10% Tris- Glycine gels (Novex, San Diego, CA) and were
transferred to nitrocellulose membrane (Schleicher & Schuell, Keene, NH). The membrane
was treated with a blocking buffer (Tris-buffered saline Tween (TBS-T) containing 5%
non-fat milk) for 1 hour and exposed to primary antibody at 4°C overnight. The membrane
was rinsed and incubated with a 1: 2000 dilution of secondary antibody for 1 hour. The
membrane was then washed with TBS-T and antibody binding sites were visualized by
ECL western blotting detection reagents (Amersham Pharmacia Biotech, Piscataway, NJ).
P53 antibody was from Santa Cruz biotechnology (Santa Cruz, CA), and phospho-p53
antibodies were from New England Biolabs (Beverly, MA).
Single Cell Gel Electrophoresis Assay (SCG assay) for DNA Damage
2.5

106 cells were seeded in 35 mm cell culture plates, incubated at 37 C and 5%

CO2 overnight. The cells were exposed to different concentrations of Cr(VI). After
incubated for 3 hours, the cells were harvested and re-suspended in the PBS at an
approximate density of 2

106 cells/ml for SCG assay.
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The SCG assay was performed according to the procedure described by Tice, et al
(41), with minor modification.100 µl 0.5% normal melting agarose (Sigma) in Ca2+ and
Mg2+ free PBS was added onto the fully frosted microscope slides. The agarose was then
covered with a 22

22 mm coverslip immediately. The slides were placed on ice for 10

minutes. 100 µl cell suspension was mixed with 900 µl low melting point (LMP) agarose
(Sigma) at 37 C. Then 75 µl of the mixture (approximate 1.5-2.0

104 cells) was pipetted

onto the first agarose layer (after gentle removal of the coverslip). The coverslip was
replaced and the slide was maintained at 4 C for solidification. After removal of the
coverslip, 75 µl of 0.5% LMP agarose was loaded. The coverslip was replaced, and the gel
was allowed to solidify for 10 minutes. The coverslip was removed and the slides were
immersed in freshly prepared cold lysing solution (2.5 M NaCl, 100 mM Na2EDTA, 10
mM Tris, and 1% sodium sarcosinate, pH = 10; 1% Triton X-100 and 10% DMSO v/v were
added just before use) for at least 1 hour at 4 C. All the following steps were conducted
under red light to prevent additional DNA damage. The slides were drained and placed in a
horizontal gel electrophoresis tray filled with fresh alkaline-EDTA buffer (300 mM NaOH
and 1 mM EDTA in distilled water, pH > 13) for 10 minutes to allow for DNA unwinding
and alkaline-labile damage expression. Electrophoresis was carried out for 50 minutes at
room temperature at 20 volts (about 1 V/cm). Then the slides were neutralized by rinsing 5
minutes with Tris buffer (0.4 M Tris, pH 7.5) for 3 times, stained with 50 µl ethidium
bromide (20 µg/ml), and covered with a coverslip. Image analysis was made at 400 ×
magnification using a fluorescence microscope (Zeiss). The length of DNA migration was
determined with an optical micrometer by measuring the tail length (distance between the
edge of head and the end of tail) in microns. A minimum of 50 cells per treatment, that is,
25 cells on each of two duplicate slides from a randomly chosen field, were scored.
Statistical analysis was performed by using Kruskal-Wallis One Way Analysis.
ESR measurements
ESR spin trapping was used to examine free radical generation. The use of this
method is necessary because of the reactive nature of the free radicals to be studied. This
technique involves an addition-type reaction of a short-lived radical with a diamagnetic
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compound (spin trap) to form a relatively long-lived free radical product, the so-called spin
adduct, which can be studied by conventional ESR (42). The intensity of the spin adduct
signal corresponds to the amount of short-lived radicals trapped, and the hyperfine
splittings of the spin adduct are generally characteristic of the original, short-lived, trapped
radical.
All measurements were conducted with a Bruker ESP 300E ESR spectrometer and a
flat cell assembly. Hyperfine couplings were measured (to 0.1G) directly from magnetic
field separation using potassium tetraperoxochromate (K3CrO8) and 1,1-diphenyl-2picrylhydrazyl (DPPH) as reference standards. Reactants were mixed in test tubes to a total
final volume of 0.5 ml. The reaction mixture was then transferred to a flat cell for ESR
measurement.
Cellular O2 - assay
Dihydroethidium (DE) is a fluorescence dye specific for superoxide radical (O2 -)
(43, 44). DE was dissolved in DMSO at 2 mM and kept at -20°C. The cells were plated
onto a glass slip in the 24 well plate at 1 × 104 cells/well 16 hours before treatment. DE was
added to the cell culture together with the various treatments and the cells were incubated at
37°C for 30 minutes. The final DMSO concentration in the cell culture was 0.1%. After
being stained, the cells were washed with PBS and fixed with 10% buffered formalin. The
slip was mounted on a glass slide and observed using a Saratro 2000 (Molecular Dynamics,
Inc., Sunnyrale, CA) laser scanning confocal microscope (Optiphot-2, Nikon, Inc.,
Melville, PA) fitted with an argon-ion laser.
Oxygen consumption measurements
Oxygen consumption measurements were carried out using a Gilson oxygraph
equipped with a Clark electrode (Gilson Medical Electronics, Middleton, WI). These
measurements were made from mixtures containing 1.0 × 106/ml cells and various
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treatments in a total volume of 1.5 ml. The oxygraph was calibrated with media equilibrated
with oxygen of known concentrations.
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IV.4. RESULTS
Ras protein mediates Cr(VI)-induced apoptosis via ROS
To investigate the role of Ras protein in Cr(VI)-induced cell response, Ras(+) cells
were developed from LNCap cells (the human prostate tumor cell line) by stable
transfection with a H-ras expression vector. Compared to Ras(-) cells (LNCap cells), Ras(+)
cells constantly express higher lever of Ras protein. Cells were treated with Cr(VI), and
DNA fragmentation assay was carried out by detection of histone-bound DNA fragments in
whole cell lysates with a cell death ELISA system as described in “Materials and Methods”.
As shown in Figure 1, without stimulation, both Ras(+) cells and Ras(-) cells showed
apoptosis at a low level. With an addition of Cr(VI), Ras(+) cells exhibited increased
susceptibility to apoptosis, although increased apoptosis was observed in both cells. These
results obtained suggest that Ras protein may play a role in Cr(VI)-induced apoptosis.
Since previous studies have demonstrated that overexpressed Ras protein is able to
produce O2 - radical, the role of ROS was examined using various specific antioxidants.
SOD, which converts O2 - radical to H2O2, enhanced apoptosis of Ras(+) cells induced by
Cr(VI). Catalase and sodium formate, specific scavengers for H2O2 and COH radical, and
metal chelator, deferoxmine, decreased Cr(VI)-induced apoptosis in Ras(+) cells. Similar
results were observed in Ras(-) cells but were less potent than in Ras(+) cells.
Ras protein mediates Cr(VI)-induced cellular DNA damage
To further address the role of Ras protein in Cr(VI)-induced cell responses, we
measured cellular DNA damage caused by Cr(VI). Ras(+) and Ras(-) cells were incubated
with various concentrations of Cr(VI) for 3 hours. The DNA damage was determined by a
single cell gel electrophoretic assay. As demonstrated in Figure 2, without Cr(VI), Ras(+)
and Ras(-) cells exhibited a similar level of DNA damage. When treated with Cr(VI),
Ras(+) cells were subjected to severe DNA damage compared to Ras(-) cells. The
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differences of DNA damage induced by Cr(VI) in Ras(+) and Ras(-) cells imply a role for
Ras protein in Cr(VI)-induced cell DNA damage.
The role of Ras in p53 activation by Cr(VI)
The p53 tumor suppressor protein plays an important role in protecting cells from
tumorgenetic alteration (45, 46). In response to DNA damage, p53 protein is activated
primarily by phosphorylation, resulting in either cell cycle arrest or apoptosis to diminish
possible genetic change (46-48). Because of the role of p53 protein in DNA damage
induced apoptosis, we examined p53 activity in Cr(VI) treated Ras(+) and Ras(-) cells.
Ras(+) cells have a higher basal p53 protein level. With the increase of Cr(VI)
concentration, both cells showed a dose-dependent increase of p53 protein but with higher
level in Ras(+) cells than in Ras(-) cells (Fig. 3a). Furthermore, antibodies specific to Ser15
and Ser392 were utilized to examine the phosphorylation of p53 protein with the
stimulation of Cr(VI). As shown in Figures 3b and 3c, while the phosphorylation of both
Ser15 and Ser392 of p53 protein was enhanced with the increase in Cr(VI) concentration.
Ras(+) cells have a higher level than Ras(-) cells.
The role of Ras protein in Cr(VI)-mediated ROS generation
The results mentioned above imply that ROS generated from Ras(+) cells by Cr(VI)
stimulation play an important role in mediating Ras protein signaling. To further
demonstrate the role of Ras protein in ROS generation, fluorescence assay was used to
directly visualize free radical generation inside the cells. Dihydroethidium (DE), a specific
fluorescent dye for O2 -, was used to detect the generation of O2 - radicals. The fluorescent
dyes exhibited a yellow or orange color after being oxidized by O2 -. As shown in Figure 4,
Ras(+) cells are capable of generating more O2 - radicals than Ras(-) cells.
Electron spin resonance (ESR) spin trapping was also used to detect the free radical
generation induced by Cr(VI). The spectrum recorded from Ras(+) cells stimulated with
Cr(VI) is shown in Figure 5a. The spectrum consists of a 1:2:2:1 quartet with splittings of

98

aH = aN = 14.9 G, where aH and aN denote hyperfine splittings of the -hydrogen and the
nitroxyl nitrogen, respectively, indicating the DMPO-OH adduct. The arrow head at the
right side shows a small peak, which was assigned to a Cr(V) based on a similar
observation reported earlier (49). Ras(-) cells treated with Cr(VI) are able to generate
similar pattern of spectrum but with much lower signal intensity (Fig. 5b). The DMPO-OH
adduct can be formed either by direct trapping of COH radical or rapid breakdown product
of DMPO-OOH (38), the adduct formed by DMPO trapping of O2 - radical. Addition of
SOD abolished the DMPO-OH adduct signal as well as Cr(V) signal (Fig. 5c). Catalase, a
scavenger of H2O2 which is a precursor of COH radical, also decreased the DMPO-OH
signal but with less potency than SOD (Fig. 5d). These results indicated that observed
DMPO-OH signal was contributed partly by O2 - trapping and partly by COH trapping. O2 functions as a precursor for both H2O2 and subsequent COH generation. Metal chelator,
deferoxamine, also abolished the spin adduct signal with a concomitant generation of
DMPO adduct of deferoxamine nitroxide radical signal (Fig. 5e). The hyperfine splittins of
this adduct are aH = 7.7 G and aN = 6.2 G and in agreement with those reported in the
literature (50). Deferoxamine nitroxide radicals were generated due to the reaction of COH
radical with deferoxamine. Because DMPO adduct of deferoxamine nitroxide radical is
stable in the cellular environment, its signal intensity was relatively strong. H2O2
dramatically increased the DMPO-OH signal with the elimination of the Cr(V) peak,
showing that COH radicals were generated in Cr(V)-mediated Fenton-like reaction (Cr(V) +
H2O2 → Cr(VI) + COH + OH-) (Fig. 5f). These observations suggest that overexpression of
Ras protein indeed plays a critical role in promoting the generation of ROS. According to
the result that SOD, but not catalase, completely abolished ROS generation induced by
Cr(VI), generation of O2 - radicals from Ras overexpression under Cr(VI) stimulation is the
major step for the production of other ROS.
The two major sources for cellular ROS generation are the flavorprotein-containing
NADPH oxidase complex and mitochondrial electron transport chain. These systems
function to reduce molecular oxygen to generate O2 - radicals. To further investigate the
possible mechanisms of the involvement of Ras in ROS generation induced by Cr(VI), we
examined the effects of two inhibitors for these enzymes and under an argon atmosphere.

99

Figure 6a shows the generation of spin adduct and Cr(V) signals from Cr(VI)-stimulated
Ras(+) cells. Addition of DPI, a potent and highly selective flavoenzyme inhibitor for
NADPH oxidase, reduced the intensity of both spin adduct and Cr(V) signals (Fig. 6b).
Rotenone, an inhibitor of mitochondrial electron transport, only slightly decreased spin
adduct signal (Fig. 6c). Both the spin adduct and Cr(V) signals decreased sharply when the
experiment was performed in an argon atmosphere, demonstrating the role of molecular
oxygen in the mechanism of ROS and Cr(V) generation (Fig. 6d). The role of molecular
oxygen as the original source for ROS generation was further verified by oxygen
consumption experiments in Ras(+) and Ras(-) cells (Fig. 7). Without Cr(VI) simulation,
Ras(+) cells consumed more oxygen than Ras(-) cells due to its ability to generate O2 radicals by itself. With the addition of Cr(VI), both cells consumed more oxygen with a
higher level in Ras(+) cells than in Ras(-) cells. The results suggest that the NADPH
oxidase is responsible for Ras mediated ROS generation from molecular oxygen in Ras(+)
cells under Cr(VI) stimulation.
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IV.5. DISCUSSION
By transfecting a H-ras expression vector stably into LNCap cells, we developed a
cell line Ras(+) that constantly overexpress Ras protein. Ras protein plays a key role in
regulating signal transduction pathways and transcription factors that are crucial in cell
growth control and apoptosis, including mitosis-activated protein (MAP) kinase pathway,
the ribosomal protein S6 kinase, PKC, c-jun, c-fos, and AP-1 (35, 51-56). Due to its central
role in cell proliferation and death, deregulation of Ras protein activity, either by
overexpression or by mutations, has been associated with tumor development (36, 37).
However, the mechanisms for Ras-induced transformation are not fully understood.
Recently, overexpression of Ras protein has been reported to generate O2 - radical through
Rac1 (38). Due to its low reactivity, O2 - radical itself is not capable of inducing NF-6B
activation or p53 activation. Therefore, the cellular response mediated by Ras pathway must
involve different reactive intermediates.
In the present studies, we have demonstrated that O2 - radical, which is produced by
overexpressed Ras protein, reacts with Cr(VI) to generate Cr(V). The Cr(V) further reacts
with H2O2, which is produced by O2 - radical dismutation, to produce COH radical. These
conclusions are supported by the following experimental observations. a) Ras(+) cells
produced more O2 - and COH radicals than Ras(-) cells after Cr(VI)-stimulation. b) SOD,
which dismutases O2 - radical to generate H2O2, abolished both COH radical and Cr(V)
signals generated by Cr(VI) stimulation, suggesting that O2 - radical acts as a source for the
generation of COH radical and Cr(V) through Haber-Weiss (Equations [1]-[3]).
O2 - + Cr(VI) → Cr(V) + O2

[1]

Cr(V) + H2O2 → Cr(VI) + COH + OH-

[2]

overall,
O2 - + H2O2

Cr(VI)/Cr(V)

O2 + COH + OH-
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[3]

c) Catalase, which is specific scavenger for H2O2, decreased COH radical signal but did not
abolishe it, indicating that COH radicals were generated and contributed to the overall spin
adduct signal observed. The COH radical generation was further supported by the
deferoxamine nitroxide radical generation with a concomitant suppression of COH radical
formation upon addition of deferoxamine.
As discussed above, Cr(VI) is able to generate a whole spectrum of ROS in Ras(+)
cells. Among these species, COH radical is the one responsible for Cr(VI)-induced DNA
damage, p53 activation and apoptosis in these cells. This conclusion is supported by our
recent studies that neither O2 - nor H2O2 is directly involved in Cr(VI)-induced DNA
damage, NF-6B activation or p53 activation (11, 30, 40), while COH radical is directly
responsible for these responses. With regard to Cr(VI)-induced apoptosis, our earlier
studies have shown that ROS are involved (57) but we did not identify which one among
these species is responsible. In the present study, we have shown that Cr(VI)-induced
apoptosis in Ras(+) cells was enhanced upon addition of SOD. This enzyme may enhance
the dismutation of O2 - to generate H2O2 and COH radical, resulting in an enhancement of
apoptosis. SOD may also reduce Cr(V) generation from Cr(VI) due to dismutation of O2 and reduced COH generation, resulting in a decrease in apoptosis. Depending on the balance
of these two factors, SOD may either enhance or decrease apoptosis. In the present study,
enhancement effect was observed, indicating that O2 - itself is not directly involved in
apoptosis. Catalase, a scavenger for H2O2, also decreased Cr(VI)-induced apoptosis in
Ras(+) cells, indicating the involvement of H2O2. However, H2O2 itself was unable to
induce apoptosis. It can cause apoptosis indirectly through its ability to generate COH
radical upon reaction with Cr(V). The following experimental observations support this
conclusion. (a) Sodium formate, an COH radical scavenger, inhibited apoptosis. This COH
radical scavenger did not react with either H2O2 or O2 -. (b) Deferoxamine, which inhibited
apoptosis due to its inhibition for COH radical generation, does not react with either H2O2 or
O2 -. Although H2O2 is not a direct apoptosis inducing agent, it functions as a precursor for
COH

radical generation. Thus elimination of H2O2 inhibited apoptosis.
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Molecular oxygen is the original source of ROS generation in Ras(+) cells under
Cr(VI) stimulation. Reduction of molecular oxygen generated O2 - as demonstrated by
oxygen consumption assay and elimination of ESR signals under an argon atmosphere. The
major reductase involved is the flavoprotein-containing NADPH oxidase complex rather
than the mitochondrial electron transfer chain. This conclusion was supported by the
inhibition of ROS generation by DPI, a highly selective flavoprotein inhibitor. Rotenone, an
inhibitor of mitochondrial electron transport chain, only exhibited slight inhibition.
Cr(VI) is a well-established carcinogen. Although the mechanisms for Cr(VI)induced carcinogenesis is not fully understood, ROS have been suggested to be involved
(26). Earlier studies in our laboratory has established a pathway for Cr(VI)-induced ROS
generation both in vitro and in vivo (26, 58). The results obtained from the present study
show that Cr(VI) can interact with O2 - radical generated by Ras protein to produce COH
radical, representing a new pathway for Cr(VI)-mediated COH radical generation. It may be
noted that a recent study has implicated O2 - radical in the Ras pathway, which is one of the
most important growth-stimulating pathways of the cells (59). Ras pathway can contribute
to cancer development if it becomes overreactive, which may happen as a result of mutation
in Ras gene or changes in other oncogenic proteins that also send their signals through Ras
pathway. While it has been reported that Ras sends its growth stimulating messages to the
nucleus through O2 - radical, it is unclear how O2 - radical relays Ras protein-mediated
oncogenic message. The results obtained from the present study show that COH radical,
which is generated from O2 - radical through H2O2 as an intermediate, is the species which
relays the message as illustrated in Figure 8. In addition to its broad importance, this
pathway presents a new scheme for ROS generation from Cr(VI)-induced cells. It also puts
Cr(VI) into the signal transduction pathways mediated by Ras protein. By generating COH
radical, which carries the signals from Ras to the nucleus, Cr(VI) plays an important role in
mediating Ras signaling pathway. Since Ras signaling pathway is important in regulating
cell proliferation, the involvements of Cr(VI) in Ras signal transduction pathway may be
one of the mechanisms for Cr(VI)-induced carcinogenesis.
It may be noted that many other metal ions, such as cobalt, nickel, vanadium,
cadmium, and arsenate have been reported to be capable of interacting with O2 - radical
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(50, 60-63). It is possible that Ras protein may have the same function on the ROS
generation induced by these agents. These agents may play an important role in Ras signal
transduction pathway similar to Cr(VI). The proposed new schemes of Ras mediated ROS
generation under Cr(VI) stimulation may fit for all these metals and contribute to their
carcinogenesis.
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IV.6. FIGURES

1400
Ras(+)
Ras(-)

Apoptosis (OD)

1200
1000
800
600
400
200
0
Control

Cr(VI)

SOD

Catalase

FormateDeferoxamine

Fig. 1 Ras protein mediates Cr(VI)-induced apoptosis. The cells were plated in a 96well plate at a density of 2 × 104 cells/well in supplemented RPMI 1640 and
incubated for 16 h before the cells were subjected to treatment in triplicate wells.
After treatment, the cells were washed twice in phosphate-buffered saline (PBS).
Apoptosis was measured by apoptosis assay described in the Materials and
Methods. Results are presented as apoptosis induced by Cr(VI) in both Ras(+) and
Ras(-) cells, comparing to the untreated control cells (means and standard deviation
of three separated assays).
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Fig. 2 Ras protein mediates Cr(VI)-induced cellular DNA damage. 2.5

106 cells were

seeded in 35mm cell culture plates, incubated at 37 C and 5% CO2 overnight. The
cells were exposed to different concentrations of Cr(VI). After incubated for 24
hours, the cells were harvested and re-suspended in PBS at an approximate density
of 2

106/ml. DNA damage was determined by single cell gel electrophoresis assay

(SCG assay) as described in the Materials and Methods. The tail length (distance
between the edge of head and the end of tail) was utilized as the measurements, the
longer the tail, more severe the damage. Values are means and standard error of
three separated experiments. Asterisks indicate a significant increase from the
control (p < 0.05), double asterisks indicate a significant decrease from Ras(+) cells
at the same dosage.
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Fig. 3 Ras protein mediates Cr(VI)-induced p53 activation. 2 × 105 cells were cultured
in each well of 6-well plates to 95% of confluency. After 6 hours treatments of
various concentrations of Cr(VI), the cells were collected for the whole cell lysates.
The activation of p53 was determined by Western blot, using specific antibodies for
p53 protein, Ser 15, and Ser 392 phospho-p53 protein, respectively. a) p53 protein
level; b) phosphorylation of p53 on Ser 15; c) phosphorylation of p53 on Ser392.
Lane 1, Ras(+) cells; lane 2, Ras(+) cells + 5 M Cr(VI); lane 3, Ras(+) cells + 10
M Cr(VI); lane 4, Ras(+) cells + 20 M Cr(VI); lane 5, Ras(-) cells; lane 6, Ras(-)
cells + 5 M Cr(VI); lane 7, Ras(-) cells + 10 M Cr(VI); lane 8, Ras(-) cells + 20
M Cr(VI). The results are representatives of three separated experiments. The
graphs reflect the quantitations of each western blot result, respectively.
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Fig. 4 Generation of O2 - radicals inside the Ras(+) and Ras(-) cells. Ras(-) cells (left
panel) and Ras(+) cells (right panel) were incubated with 150 M Cr(VI) in the
presence of 2 M dihydroethidium for 30 minutes. The cells were washed once in
PBS and fixed with 10% formalin. The images were captured with a confocal
microscope. The results are representatives of three separated experiments.
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Fig. 5 Generation of free radicals from Cr(VI)-stimulated Ras(+) and Ras(-) cells. (a)
ESR spectrum recorded 10 minutes after the addition of 2 mM Cr(VI) to 1 × 106
Ras(+) cells/ml and 100 mM DMPO in a phosphate buffered solution (pH 7.4). (b)
Same as (a) but using Ras(-) cells. (c) Same as (a) but with 200 units/ml SOD
added. (d) Same as (a) but with 1,000 units/ml catalase added. (e) Same as (a) but
with 2 mM deferoxamine added. (f) Same as (a) but with 2 mM H2O2 added. The
results are representatives of three separated experiments.
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Fig. 6 Ras mediated ROS generation is mediated by NADPH oxidase. (a) ESR
spectrum recorded 10 minutes after the addition of 2 mM Cr(VI) to 1 × 106 Ras(+)
cells/ml and 100 mM DMPO in a phosphate buffered solution (pH 7.4). (b) Same as
(a) but with 20 M DPI added. (c) Same as (a) but with 50 M rotenone added. (d)
Same as (a) but performed under Argon. The results are representatives of three
separated experiments.
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Fig.7 Oxygen consumption by Cr(VI)-stimulated Ras(+) and Ras(-) cells. A
incubation mixture contained 1 mM Cr(VI), 1 × 106 cells/ml cells and various
reagents as indicated. Values are means and standard deviation of three separated
experiments.
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Fig.8 Schematic representation of possible mechanism of ROS generation in Cr(VI)stimulated Ras(+) cells.
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OVERALL CONCLUSIONS

1. Cr(VI) is able to induce the p53 activation in a dose- and time-dependent manner. ROS
generated from Cr(VI) stimulation are involved in the mechanism of p53 activation.
Among the ROS, COH radical functions as a messenger in the p53 activation processes.
2. In the process of p53 activation induced by Cr(VI), post-translational modifications,
including Ser 15 phosphorylation, Lys 382 acetylation, and mdm2 dissociation, play
crucial roles. Erk, but not p38 kinase, is responsible for the phosphorylation of the Ser
15 induced by Cr(VI).
3. Nuclear transcription factor NF-κB plays an important role in protecting cells from
apoptosis in response to Cr(VI) stimulation. The protection is mediated through the
inhibition of p53 protein activation, primarily by abolishing the N-terminal
phosphorylation induced by Cr(VI).
4. Ras oncoprotein mediates O2 - radical generation through reduction of molecular oxygen
by NADPH oxidase in Cr(VI)-stimulated cells. The O2 - radical and Cr(VI) produce
other reactive species, including H2O2, COH radical, and Cr(V) through O2 - dismutation
and Haber-Weiss type of reactions. Among these reactive species, COH radical is
responsible for the further transduction of signals from Ras to the nucleus, leading to
various cell responses.
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